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ABSTRACT
With significant progress made in the design and instrumentation of optical imag-
ing systems, it is now possible to perform high-resolution tissue imaging in near
real-time. The prohibitively large amount of data obtained from such high-speed
imaging systems precludes the possibility of manual data analysis by an expert. The
paucity of algorithms for automated data analysis has been a major roadblock in
both evaluating and harnessing the full potential of optical imaging modalities for
diagnostic applications. This consideration forms the central theme of the research
presented in this dissertation.
Specifically, we investigate the potential of automated analysis of data acquired
from a multimodal imaging system that combines fluorescence lifetime imaging (FLIM)
with optical coherence tomography (OCT), for the diagnosis of atherosclerosis and
oral cancer. FLIM is a fluorescence imaging technique that is capable of providing
information about autofluorescent tissue biomolecules. OCT on the other hand, is a
structural imaging modality that exploits the intrinsic reflectivity of tissue samples
to provide high resolution 3-D tomographic images. Since FLIM and OCT provide
complimentary information about tissue biochemistry and structure, respectively,
we hypothesize that the combined information from the multimodal system would
increase the sensitivity and specificity for the diagnosis of atherosclerosis and oral
cancer.
ii
The research presented in this dissertation can be divided into two main parts.
The first part concerns the development and applications of algorithms for providing
quantitative description of FLIM and OCT images. The quantitative FLIM and OCT
features obtained in the first part of the research, are subsequently used to perform
automated tissue diagnosis based on statistical classification models. The results of
the research presented in this dissertation show the feasibility of using automated
algorithms for FLIM and OCT data analysis for performing tissue diagnosis.
iii
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1. INTRODUCTION
The past couple of decades have seen an increasing interest in the development
of a wide range of new optical imaging techniques for biomedical diagnostics [1–5].
Part of the reason for this upsurge lies in the fact that each imaging modality has
its own set of strengths and limitations, which makes it suitable for certain appli-
cations but not others. For example, while confocal imaging is capable of providing
sub-micron cellular resolution images, it has a limited tissue penetration depth of
several hundreds of microns. In comparison, a typical Optical Coherehce Tomogra-
phy (OCT) imaging system has a relatively poorer resolution of several microns, but
has a higher penetration depth of couple of millimeters. In addition to resolution
and penetration depth, different imaging modalities could also have different sources
of contrast. Thus, while structural imaging modalities like confocal microscopy and
OCT use the back-scattered light to provide rich details about cellular and tissue
morphology, fluorescence imaging modalities depend on fluorescence as the source
of contrast to provide information about tissue biochemistry. Because no single
imaging modality can provide satisfactory performance in all respects (resolution,
penetration depth, sensitivity, SNR, acquisition speed, cost, etc.), considerable re-
search in recent years has focused on the development of multimodal imaging systems
to utilize the strengths of different imaging modalities for achieving better diagnostic
accuracy [6–11].
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1.1 Significance
In this dissertation, we investigate the potential of a multimodal imaging system
that combines Fluorescence Lifetime Imaging (FLIM) with OCT for the diagnosis
of atherosclerosis and oral cancer. FLIM is a fluorescence imaging technique that
is capable of providing information about autofluorescent tissue biomolecules. OCT
on the other hand, is a structural imaging modality that exploits the intrinsic reflec-
tivity of tissue samples to provide high resolution 3-D tomographic images. Since
FLIM and OCT provide complimentary information about tissue biochemistry and
structure, respectively, we hypothesize that the combined information from the multi-
modal system will increase the sensitivity and specificity for detecting atherosclerotic
plaques and oral cancer in early stages. To better understand the significance of the
combined structural and functional imaging in the context of the scope of this disser-
tation, a brief discussion on the biochemical and morphological changes associated
with the pathophysiology of atherosclerosis and oral cancer is presented next.
1.1.1 Atherosclerosis
Atherosclerosis is a vascular disease characterized by the progressive thickening
of arterial walls through a process of inflammation [12], which is accompanied by the
accumulation of lipids, calcium and several cellular components of blood like white
blood cells, macrophages, and smooth muscle cells, resulting in the formation of an
atherosclerotic plaque. A class of atherosclerotic plaques called the vulnerable plaques
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are characterized mainly by a thin fibrous cap and an underlying lipid-rich core.
These plaques are prone to rupture, releasing thrombogenic material into the blood-
stream, leading to an acute ischemic event. In fact, it is known that two-thirds of the
deaths resulting from coronary events are caused by rupture of vulnerable plaques or
some form of plaque erosion [13]. Efficient diagnosis of vulnerable plaques is therefore
of paramount importance for the treatment of high-risk patients suffering from coro-
nary artery diseases. While a fluorescence imaging modality like FLIM is capable of
characterizing a plaque’s biochemical content, it does not provide any information
about its morphology. On the other hand, a structural imaging modality like OCT
can provide high resolution tomographic images of plaques, but it cannot offer any
information about their biochemistry. Because the development of an atherosclerotic
plaque involves complex interactions between tissue morphology and biochemistry, a
multimodal imaging system is needed for a comprehensive assessment and directed
treatment of atherosclerotic plaques.
1.1.2 Oral Cancer
Oral cancers have an overall five-year survival rate of approximately 60%. How-
ever, when detected in early stages, oral cancers can have a five-year survival rate
as high as 80-90% [14]. Early detection of oral cancer, therefore, holds the key for
improving survival rates and reducing the need for disfiguring surgical interventions,
which significantly compromises the quality of life of survivors. Diagnosis of oral
cancer in late stages can be mainly attributed to the current method of diagnosis
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of oral malignancies, which is primarily based on a visual inspection of oral lesions,
followed by biopsies in suspicious cases. The distinction between a benign and a
malignant lesion is, however, not always very clear by a mere visual examination. In
the absence of a reliable screening tool, therefore, it is not easy to determine which
abnormal looking lesions in the oral cavity are worthy of concern. Since it is imprac-
tical to perform biopsies on every suspicious lesion, the standard protocol is to watch
a lesion over an extended period of time to determine if it is indeed malignant. This
often leads to a situation where a potentially malignant lesion, which might be easily
treatable at an earlier stage, advances into a later untreatable condition. It is known
that the progression of a malignant lesion from an early stage to later stages is ac-
companied by both biochemical changes like alterations in the relative abundances of
tissue autofluorophores [15–17] and morphological changes like epithelial thickening
and loss of the layered tissue structure [18–21]. An imaging system, capable of pro-
viding information about both tissue biochemistry and morphology, could therefore
serve as an effective screening tool for the early diagnosis of oral cancer.
1.2 Objectives and Dissertation Outline
Recent advances in optical imaging technology and instrumentation has enabled
the acquisition of large volumes of data in near real-time. For example, the high
speed multimodal FLIM-OCT system used in this study is capable of acquiring
high-resolution co-registered FLIM and OCT data over a 2×2 mm2 field of view in
approximately 7 seconds. The vast amount of data acquired by such high-speed
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imaging systems makes direct human interpretation virtually impossible. The need
for automated data analysis is even more pressing in the case of multimodal imaging,
where the information obtained from the constituent modalities needs to be synergis-
tically integrated to make the most of the intrinsic advantages of the complimentary
nature of information provided by the individual modalities. The paucity of such
algorithms for automated image analysis has been a major roadblock in both eval-
uating and harnessing the full potential of optical imaging modalities for diagnostic
applications. This consideration forms the central theme of this dissertation. In this
spirit, the remaining sections of this dissertation are organized as follows.
Section 2 provides a concise overview of FLIM and OCT, along with an intro-
duction to several basic concepts and definitions pertaining to FLIM and OCT data
processing. This is followed by Section 3, which gives a brief description of the mul-
timodality FLIM-OCT system and the tissue datasets used in the studies presented
in this dissertation. Section 4 desribes a novel automated deconvolution algorithm
for FLIM data analysis. This deconvolution algorithm forms the core of FLIM data
processing presented in this dissertation. In Section 5, a new set of FLIM features
based on nonnegative matrix factorization (NMF) of multispectral FLIM data are
proposed. These features are more intuitive and easier to interpret than the stan-
dard fluorescence intensity and lifetime features. The performance of the new set of
FLIM features is also compared against the standard FLIM features. A discussion
on how a quantitative classification based on FLIM-derived biochemical features can
5
be combined with qualitative information obtained from OCT images to perform a
comprehensive evaluation of atherosclerotic plaques is presented next in Section 6.
In Section 7, automated algorithms for quantifying structural features in OCT im-
ages of hamster cheek pouches (the animal model used for oral cancer) are presented.
The feasibility of performing automated diagnosis of pre-malignant and malignant
oral lesions, by combining these morphological features with FLIM features in a sta-
tistical classification framework, is also demonstrated. Finally, in Section 8, some
concluding remarks are presented.
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2. OVERVIEW OF FLUORESCENCE LIFETIME IMAGING
MICROSCOPY AND OPTICAL COHERENCE TOMOGRAPHY
2.1 Basics of Fluorescence∗
Fluorescence is a phenomenon in which light absorption by a molecule is fol-
lowed by spontaneous emission of light of a longer wavelength, typically within few
nanoseconds after absorption. The absorption of light results in the excitation of the
molecule from its ground state to a higher energy electronic state, and the subsequent
emission is a result of the molecule returning back to its ground state. In general,
a molecule can relax to its ground state from an excited electronic state through
several mechanisms. These mechanisms are illustrated through a Jablonski diagram.
To understand the process of fluorescence, a simplified Jablonski diagram is shown
in Fig. 2.1, where the electronic states are represented as gray bands. The two elec-
tronic states, denoted by S0 and S1 denote the lowest energy state (most populated
and stable energy state at room temperature, also called the ground state) and the
first excited electronic state, respectively. Each electronic state further has several
vibrational energy states that are shown as a set of closely spaced lines within each
electronic state. Excitation of a molecule by absorption of light occurs when the en-
ergy of the incident photons matches the difference in the energy levels of the lowest
vibrational level in the ground state and some vibrational level in an excited elec-
∗A detailed exposition of fluorescence imaging can be found in the introductory chapters of [22]
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Figure 2.1: Simplified Jablonski diagram illustrating the various electronic and vi-
brational states of a molecule and the transitions.
tronic state (S1 in Fig. 2.1). This transition from ground state to a higher electronic
state, shown by blue arrows in Fig. 2.1, occurs over a time scale of femtoseconds.
The absorption of light is followed by relaxation of the molecule to the lowest
vibrational state of the first excited electronic state (shown by orange squiggly arrows
in Fig. 2.1). This transition is a non-radiative process, which happens in the order of
picoseconds and is called vibrational relaxation or internal conversion if the transition
occurs between the vibrational states of different excited electronic states (not shown
in Fig. 2.1). The molecule residing in the lowest vibrational state of the first excited
electronic state may subsequently relax to one of the vibrational states of its ground
state through a radiative process, in accordance with the Kasha’s rule [22], which
states that the transition between an excited energy state to a lower energy state
8
Absorption Emission
Figure 2.2: Absorption and emission spectra of a fluorophore illustrating the mirror-
image symmetry property.
usually takes place from the the lowest vibrational state of the excited state. This
radiative process which typically takes place on time scales of nanoseconds, is called
fluorescence (shown by red arrows in Fig. 2.1). While in most cases, radiative decay
occurs from the lowest vibrational state of the first excited state to a vibrational
state of the ground state, some exceptions exist where molecules fluoresce directly
from a higher excited electronic state; although, such cases are rare.
As mentioned earlier, depending on the excitation photon energy, a molecule can
be excited from its ground state to any vibrational state of a higher energy electronic
state, resulting in a broad absorption spectrum. Of the several possible transitions,
some are more likely than others; the most probable transition from the ground
state to an excited state being the one corresponding to the peak of the absorption
spectrum. Likewise, the several possibilities for the transition between the lowest
vibrational level of the first excited electronic state to the ground state, results in
9
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Figure 2.3: Time-resolved measurement techniques. (a) Time-domain lifetime mea-
surements are performed by exciting the sample by a short light pulse and the lifetime
τ is calculated by estimating the rate of decay of the recorded decay (shown for a
simple exponential decay). (b) Lifetime estimation based on frequency-domain life-
time measurements. The sample is excited by an intensity modulated light source
(sinusoidally with angular frequency ω in the example shown in the figure). The
phase shift φ and modulation m of the emission signal with respect to the excitation
waveform is used to estimate the lifetime. The two lifetimes, τφ and τm yield the
same value for a sample exhibiting an exponential decay dynamics. In the case of
complex decay dynamics, the two lifetimes represent apparent lifetimes and advanced
computational methods are required to extract the true lifetime.
a broad emission spectrum. According to the Frank-Condon principle [22], in most
cases, if the probability of transition from the lowest vibrational level of S0 to say, nth
vibrational state of S1 is highest during absorption, then the probability of relaxation
from the lowest energy vibrational state of S1 to the nth vibrational state of S0 is also
the highest during emission. This results in a symmetric absorption and emission
spectra as shown in Fig. 2.2, where the shift in spectra, called the Stokes shift,
corresponds to the energy loss resulting from the non-radiative relaxation transitions.
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2.2 Steady-state and Time-resolved Fluorescence Measurements
Fluorescence measurements can be classified into two broad categories: steady-
state and time-resolved. In steady-state measurements, a fluorescent sample is usu-
ally excited at its peak absorption wavelength by a continuous light source and the
fluorescence intensity is recorded at different emission wavelengths to obtain the
emission spectrum of the sample. Due to the nanosecond timescale of fluorescence
decay, the sample under continuous excitation, reaches steady-state almost immedi-
ately after excitation, and hence, the measurements obtained in this way are called
steady-state measurements. Time-resolved measurements on the other hand are
aimed at characterizing the sample’s fluorescence decay dynamics. These measure-
ments can be performed in either time-domain or frequency-domain as illustrated
in Fig. 2.3. In time-domain fluorescence measurements, the sample is excited by a
short pulse of light and the subsequent emission intensity is measured as a function
of time using a high speed photo-detector. The fluorescence dynamics of the sample
is characterized by measuring the rate of decay of the recorded time-resolved emis-
sion intensity. As shown in Fig. 2.3 (a), the rate of decay, denoted by τ , is called the
lifetime, which in the simplest case of an exponential decay (and an ideal infinitesi-
mally short excitation pulse) is the time it takes for the emission intensity to decay
to 37% of its maximum value. In frequency-domain measurements, a high speed in-
tensity modulated (usually sinusoidally) light source is used as the excitation source.
The fluorescence emission under such excitation is also modulated in the same way
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as the excitation light, but has a decreased modulation depth and is phase shifted
with respect to the excitation signal. The lifetime of the sample is determined by
computing the phase shift and the demodulation factor using the equations shown
in Fig. 2.3 (b). For a sample exhibiting a mono-exponential decay dynamics, mea-
surement at one modulation frequency ω, is enough, and the two lifetimes, τφ and τm
are equal. For multi-exponential or non-exponential decays, phase and modulation
measurements at multiple modulation frequencies are needed, and the true lifetime
is estimated by model fitting [23].
The time-resolved fluorescence data used in this dissertation was obtained using
a time-domain system described in Section 3.1.1; all subsequent discussion on time-
resolved measurements will, therefore, pertain to time-domain systems.
So far, the concept of lifetime has been couched in relatively general terms as a
measure of the rate of decay of fluorescence emission intensity. For a more rigorous
definition of lifetime, consider the simplest case, where the relaxation process of a
fluorescent molecule, from an excited state to its ground state, can be described by
a first-order rate law:
dN(t)
dt
∝ −N(t). (2.1)
Here, N(t) denotes the number of molecules in the excited state at a given time, t.
Introducing a constant of proportionality, k, which represents the rate constant of
the decay dynamics, and assuming that the initial population of the excited state is
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N0, the differential rate law in Eq. (2.1) can be solved as below:
dN(t)
dt
= −kN(t)∫ N(t)
N0
dN(t)
N(t)
= −
∫ t
0
k dt
N(t) = N0e
−kt
(2.2)
Because the intensity of fluorescence emission is proportional to the population of the
excited state, the above time-dependent relationship can be equivalently expressed
in terms of fluorescence intensity. The constant, 1/k, is called the lifetime, and
henceforth, shall be denoted by τ as shown below:
I(t) = I0e
−t/τ (2.3)
The equation above describes the shape of the time-resolved decay, when the excita-
tion light pulse is infinitesimally narrow. In practice, however, the excitation pulse
width is finite, which results in a modified shape of the recorded decay as shown in
Fig. 2.3 (a). Mathematically, the recorded decay can be expressed as the convolution
of the excitation pulse with the true fluorescence decay described by Eq. (2.3). To
retrieve the true fluorescence decay from time-resolved measurements, the excitation
pulse, therefore, has to be deconvolved from the recorded decay. Deconvolution is an
important concept in fluorescence lifetime imaging as discussed briefly later in this
section, and in more detail in Section 4.
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In Eq. (2.3), lifetime was defined as the inverse of the rate constant of the assumed
first-order fluorescence decay dynamics. There is, however, another interpretation of
lifetime, which is based on the understanding that fluorescence emission is a stochas-
tic process. This means that in an ensemble of fluorescent molecules, a particular
molecule spends a random amount of time in the excited state before relaxing to its
ground state. Eq. (2.3) can then be interpreted as a stochastic decay law, where the
constant τ , characterizes the average time that a fluorescent molecule spends in its
excited state. This definition can be verified for the decay law expressed in Eq. (2.3)
as shown below:
t¯ =
∫∞
0
tI(t) dt∫∞
0
I(t) dt
=
∫∞
0
tI0e
−t/τ dt∫∞
0
I0e −t/τ dt
= τ (2.4)
While the above calculation for lifetime estimation has been worked out for a mono-
exponential decay, the preceding definition of lifetime can also be used to estimate
the lifetime of any complex decay law, I(t). For example, for a bi-exponential decay
law of the form: I(t) = a1e
−t/τ1 + a2e −t/τ2 , the lifetime (also called the average
lifetime) can be estimated as:
τ ≡ τavg = t¯ =
∫∞
0
t
(
a1e
−t/τ1 + a2e −t/τ2
)
dt∫∞
0
a1e −t/τ1 + a2e −t/τ2 dt
=
a1τ1
2 + a2τ2
2
a1τ1 + a2τ2
(2.5)
2.3 Fluorescence Lifetime Imaging
Simply put, FLIM is a fluorescence imaging technique in which time-resolved
fluorescence measurements are performed over a two-dimensional FOV. A typical
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Figure 2.4: Signal processing cascade for multispectral FLIM data processing.
Schematic illustrates the process of obtaining the normalized intensity maps and
lifetime maps from a 3 channel multispectral FLIM data cube. The first step in
the process is splitting the spectro-temporal cube into three temporal cubes (shown
by blue arrows): one cube per wavelength channel. The normalized intensity and
lifetime maps are then obtained from the temporal cubes by a normalization proce-
dure (dashed lines, also see legend) and time deconvolution (solid lines), respectively.
(Reproduced with permission from: P. Pande, B. E. Applegate, and J. Jo, “Appli-
cation of non-negative matrix factorization to multispectral FLIM data analysis,”
Biomedical Optics Express, vol. 3, no. 9, pp. 2244–2262, 2012. c©2012 OSA)
dataset from a FLIM imaging system is three-dimensional, where in addition to
the temporal dimension, there are two additional spatial dimensions corresponding
to different spatial locations on the sample. In applications like tissue imaging,
where there are more than one fluorophore emitting in different wavelength bands,
multispectral FLIM can be used, in which, FLIM measurements are performed for
several emission bands (also called channels). The multispectral FLIM data used
in this dissertation was acquired using a three-channel FLIM system described in
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Section 3.1.1. The unique detection scheme of the aforementioned FLIM system
employs a set of dichroic mirrors and optical fibers of different lengths to temporally
delay the fluorescence decays in the three emission bands with respect to each other.
This arrangement produces a 3-D FLIM data cube, where the temporal dimension
contains the concatenated fluorescence decays from the three channels.
Fig. 2.4 illustrates the signal processing cascade for obtaining intensity and life-
time maps from a 3-D data cube (labeled FLIM image cube) acquired using the
three-channel FLIM system. The 3-D FLIM data cube is first split into three differ-
ent FLIM data cubes, one for each wavelength band. These FLIM data cubes, de-
noted by I(x, y, t;λ1), I(x, y, t;λ2) and I(x, y, t;λ3) in Fig. 2.4, contain the recorded
time-resolved intensity at different spatial points on the sample corresponding to
pixel locations (x, y). Next, intensity map for each wavelength band are obtained by
integrating in time, the measured fluorescence decays in each FLIM data cube. The
normalized intensity maps are then obtained by dividing the intensity value at each
pixel in an intensity map by the sum of the intensity values at that pixel in the inten-
sity maps for each wavelength band. This process of normalization is illustrated by
dashed arrows in Fig. 2.4. Finally, to obtain a lifetime map for each wavelength band,
the measured temporal decays in a FLIM data cube corresponding to a wavelength
band are deconvolved (illustrated by solid black arrows in Fig. 2.4), and the lifetime
values are subsequently obtained based on the definition of lifetime presented in
Eq. 2.4. The multispectral FLIM data is finally presented in the form of a set of nor-
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malized intensity and lifetime maps, denoted by In(x, y;λ1), In(x, y;λ2), In(x, y;λ3)
and τ(x, y;λ1), τ(x, y;λ2), τ(x, y;λ3), respectively as shown in Fig. 2.4.
2.4 Optical Coherence Tomography
A typical OCT system consists of an arrangement similar to a Michaelson’s inter-
ferometer, where light from a low coherence source is split into two directions called
the reference arm and the sample arm. In a fiber based implementation of Michael-
son’s interferometer, light in the reference arm is directed back after reflection from a
mirror to the 2×2 fiber coupler, where it gets combined with the backscattered light
from the sample in the sample arm, to generate an interference pattern, which con-
tains information about the depth reflectivity profile of the sample. Like FLIM, OCT
can also be performed in either time or frequency-domain. In a time-domain OCT
(TD-OCT) system, the mirror in the reference arm is mechanically translated across
the full imaging depth. At each position of the reference mirror, the intensity of the
interference signal is recorded by a photodetector as shown in Fig. 2.5 (a). The depth
reflectivity profile is obtained by analyzing the envelope of the temporal interference
pattern recorded by the photodetector. The main drawback of a TD-OCT system is
that the reference arm mirror has to be mechanically translated, which significantly
limits the data acquisition speed. A frequency-domain (also called Fourier-domain
or spectral-domain) OCT (FD-OCT) system differs from a TD-OCT system in that
the mirror in the reference arm of a FD-OCT system is fixed and the spectrally
resolved interferogram is collected using a spectrometer and a line camera as shown
17
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Figure 2.5: Optical coherence tomography optical setups. (a) Time-domain OCT
system: The reference arm in a time-domain OCT system consists of a mirror that
is mechanically translated to produce a time-varying path-length. The envelope of
the temporal interference signal obtained by combining the beam reflected from the
mirror in the reference arm and the backscattered light from the sample is analyzed
to obtain the depth-resolved reflectivity profile of the sample. (b) Frequency-domain
OCT system: The reflected beam from a fixed reference mirror and the backscat-
tered light from the sample is recombined at the fiber coupler and the axial depth
scan reflectivity profile is obtained by analyzing the spectrally encoded information
contained in the interference signal obtained by using a spectrometer.
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in Fig. 2.5 (b). The depth reflectivity profile, in the case of a FD-OCT system is ob-
tained by performing an inverse Fourier transform of the interference signal obtained
at the detector. Due to the fast imaging capability and high signal-to-noise (SNR)
of FD-OCT systems [24], FD-OCT system is the most commonly used type of OCT
system.
The OCT data used in this dissertation was acquired using a frequency-domain
OCT system described in Section 3.1.2. We, therefore, focus our subsequent discus-
sion on FD-OCT. Details about a TD-OCT system can be found in any standard
text on OCT like [25,26].
2.5 Signal Processing in a FD-OCT System∗
To understand the basics of image formation in an OCT system, consider the
simplest case in which the sample is modeled as a collection of N discrete re-
flectors having electric field reflectivities rS1, rS2, . . . , rSN and located at distances
zS1, zS2, . . . , zSN from the beam-splitter (See Fig. 2.6 (a)). The depth-dependent re-
flectivity profile rS(zS) for such a sample can then be mathematically expressed as
a sum of N dirac-delta pulses as: rS(zS) =
∑N
n=1 rSnδ(zS − zSn). By definition, the
power reflectivity is equal to the magnitude squared of its electric field reflectivity,
i.e. RSn = |rSn|2. The goal of OCT imaging is to reconstruct the function rS(zS)
from the interferometric measurements.
The electric field of the broadband or polychromatic light source can be expressed
∗The formulations and theory presented in this section are heavily borrowed from [27]
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in complex form as Ei = s(k, ω)e
i(kz−ωt). Here, s(k, ω) represents the contribution of
monochromatic light of wave-number k = 2pi
λ
and angular frequency ω = 2piν to the
electric field amplitude of the polychromatic light. As usual, the wavelength λ and
frequency ν are related by the refractive index n(λ) of the medium of propagation as
n(λ) = c
νλ
, where c denotes the velocity of light in vacuum. The electric field of the
light passing through the 50/50 beam-splitter after getting reflected from the sample
can then be expressed as ES =
Ei√
2
(
rS ∗ ei2kzS
)
, where ∗ represents the convolution
operation, the factor of 1√
2
represents the 50% reduction in intensity of light due to
the beam-splitter and the factor of 2 in the exponential term represents the round-
trip path of the light in the sample arm. The expression for ES can be simplified
by using the property of convolution operation to yield ES =
Ei√
2
∑N
n=1 rSne
i2kzSn .
Likewise, the expression for the electric-field of light in the reference arm can be
written as ER =
Ei√
2
rRe
i2kzR . The interference signal detected at the photo-detector
ID(k) is the time average of the intensity signal resulting from the phasor sum of ER
and ES, i.e.
ID(k, ω) =
ρ
2
〈|ER + ES|2〉 (2.6)
where ρ denotes the responsivity of the photodetector and the factor of 2 reflects the
halving of intensity on the second pass of light through the beam-splitter. Simplifying
the above expression based on the fact that the electric field oscillations are much
faster than the responsivity of the photodetector, we get an expression involving only
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Figure 2.6: (a) Optical setups of a Fourier-domain OCT system (b) Signal processing
steps involved in generating an A-line I(z) from the raw Fourier-domain OCT data
ID(λ).
time invariant terms as:
ID(k) =
ρ
4
[S(k) (RR +RS1 + . . .+RSN)] +
ρ
2
[
S(k)
N∑
n=1
√
RRRSn cos [2k (zR − zSn)]
]
+
ρ
4
[
S(k)
N∑
n6=m=1
√
RSnRSm cos [2k (zSn − zSm)]
] (2.7)
Here, S(k) = 〈|s (k, ω) |2〉 denotes the spectral dependence of the power of the light
source, which for most practical applications is assumed to be Gaussian and is ex-
pressed in terms of the central wavelength and the bandwidth of the light source ko
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and ∆k, respectively, as follows:
S(k) =
1
∆k
√
pi
e−[
(k−ko)
∆k ]
2
(2.8)
The first term in Eq. (2.7) corresponds to the DC component of the signal. This
term carries no information about the location of reflectors in the sample. The second
term, called the “cross-correlation” term is the desired component for OCT imaging,
because it contains information about the location of reflectors in the sample (coded
in the frequency of the cross-correlation terms) and the sample reflectivties (coded in
the amplitude). Finally, the third term, called the “autocorrelation” term, contains
information about the mutual separation between different reflectors in the sample.
In the context of FD-OCT, the wavelength resolved intensity signal, ID(k), is
measured by using a combination of a spectrometer and a line camera. To obtain
the reflectivity profile of the sample, an inverse Fourier transform of Eq. (2.7) is
performed, which results in the depth-resolved intensity signal I(z), also called an
“A-line” as:
I(z) =
ρ
8
[γ(z) (RR +RS1 + . . .+RSN)] +
ρ
4
[
γ(z) ∗
N∑
n=1
√
RRRSn [δ (z ± 2(zR − zSn))]
]
+
ρ
8
[
γ(z) ∗
N∑
n=1
√
RSnRSm [δ (z ± 2(zSn − zSm))]
] (2.9)
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which can be further simplified to:
I(z) =
ρ
8
[γ(z) (RR +RS1 + . . .+RSN)] +
ρ
4
[γ(z) (2 (zR − zSn)) + γ(z) (−2 (zR − zSn))] +
ρ
4
[γ(z) (2 (zSn − zSm)) + γ(z) (−2 (zSn − zSm))] .
(2.10)
In the above expression, γ(z) is called the coherence function and is related to the
power spectral dependence of the light source by a Fourier transform:
γ(z) = e−z
2∆k2 F←→ S(k) = 1
∆k
√
pi
e−[
(k−ko)
∆k ]
2
(2.11)
Intuitively, this means that the bandwidth of the light source is inversely related
to the width of the coherence function. This relationship is significant because it
relates the spectral width of the light source with the axial resolution of the imaging
system. This is clear from Eq. (2.9), where it can be seen that the depth-resolved
intensity signal is the convolution of the delta pulses at true locations with the
coherence function γ(z). Thus a narrower coherence function (or equivalently wide
bandwidth light source) would result in sharper peaks corresponding to the locations
of the reflectors in the sample, or a better axial resolution; whereas, a wider coherence
function (or a narrow bandwidth light source) would produce smudged peaks in the
depth-resolved intensity signal. In fact, the axial resolution for an OCT system is
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indeed defined in terms of the coherence length lc as:
axial resolution = lc =
2
√
ln2
∆k
=
2 (ln2)
pi
λ2o
∆λ
(2.12)
We conclude this section with a brief description of the various signal processing
steps involved in FD-OCT imaging, as shown in Fig. 2.6 (b). The first step in the
sequence of steps is the background subtraction, which involves getting rid of the
DC component in Eq. (2.7). The DC component can be optically estimated by
recording the signal at the detector when no sample is present in the sample arm.
This signal can be subtracted from the spectral interferometric signal ID(k) to get
rid of the DC component. For the data used in this dissertation, the approximation
to the background signal was obtained computationally by averaging the A-lines
in a 2-D OCT scan (also called a B-scan, which is obtained by scanning the light
beam laterally along the sample). The next step in the FD-OCT signal processing
cascade is resampling. As noted earlier, the spectral interferometric signal ID(k)
recorded by the spectrometer and line-camera combination is uniformly sampled
in wavelength (sampling resolution decided by the line spacing of the spectrometer
grating). In order to obtain depth-resolved signal I(z) from ID(k), Fourier transform
needs to be performed. However, this necessitates that the spectrally resolved data
is evenly spaced in k-space. The conversion of evenly spaced data in λ-space to
evenly spaced data in k-space is called resampling. To resample the signal, the
known unevenly spaced k-space points corresponding to say, I evenly spaced λs:
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ki =
2pi
λi
, i = 1, 2, · · · , I are used for interpolation to obtain the value of the spectral
signal at evenly spaced k-space points given by ki = kmin + (i−1) δk, i = 1, 2, · · · , I,
where kmin =
2pi
λmax
and δk =
1
I
[
2pi
λmin
− 2pi
λmax
]
. In this study, linear interpolation
was used to resample the k-space data. The resampled k-space data is then Fourier
transformed and the magnitude of the transformed data yields the depth-resolved
reflectivity profile of the sample.
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3. COMBINED FLIM-OCT IMAGING SYSTEM AND TISSUE
DATASETS*
3.1 Combined FLIM-OCT Imaging System
In this section, we present a brief description of the combined FLIM-OCT system
used to acquire the data used in this dissertation. More details about the design of
the system and its validation can be found in [28]. The schematic of the combined
FLIM-OCT system, shown in Fig. 3.1, can be better understood in terms of three
main functional blocks: (i) FLIM sub-system (on the right), (ii) OCT sub-system
(on the left), and (iii) the common path (in the center). The light path in the OCT
sub-system is shown in red. Fluorescence excitation is likewise shown by dark blue
arrows and the fluorescence emission in the three bands is shown in light blue, cyan,
and green. All other hardware interfacing is shown by black lines. In the following
sections, we present a brief description of the FLIM and OCT sub-systems, system
control, and data processing.
3.1.1 FLIM Sub-system
The multipsectral FLIM system was implemented following a direct pulse-recording
scheme, in which pixel rate could be equal to the laser repetition rate. A frequency
*Parts of this section are reproduced with permission from J. Park, J. Jo, S. Shrestha, P.
Pande, Q. Wan, and B. E. Applegate, “A dual-modality optical coherence tomography and fluores-
cence lifetime imaging microscopy system for simultaneous morphological and biochemical tissue
characterization,” Biomedical Optics Express, vol. 1, pp. 186–200, 2010. c©OSA
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Figure 3.1: Optical setup of the dual-modality FLIM-OCT imaging system. L1, L2
and L5: open-aired collimation and coupling lenses, L3, L4, L6-L10: fiber-connected
collimation and coupling lenses, NDF: neutral density filter, M1-M4: mirrors, DM1-
DM4: dichroic mirrors, and F1-F4: filters.
tripled Q-switched Nd:YAG laser (SPOT-10-50-355, Elforlight Ltd., England) was
used as the excitation source (355 nm, 30 kHz maximum repetition rate, 1 ns pulse
FWHM). A 50µm multi-mode fiber was used to deliver the excitation light to the
FLIM-OCT common path. The emission light exiting the FLIM-OCT common
path was directed through a 200µm multi-mode fiber into a multi-spectral detection
module, where the fluorescence emission was separated into three spectral channels,
namely, 390± 20 nm, 452± 22.5 nm, and 600±1 25 nm, using a set of dichroic mir-
rors and filters (Chroma Technology, Bellows Falls, VT). The emission from each
channel was launched into fibers with different lengths (1 m, 10 m and 19 m) cho-
sen to provide 45 ns interval between each emission band decay. The emission
27
bands were selected to target tissue endogenous fluorophores like flavin adenine din-
ucleotide (FAD), nicotinamide adenine dinucleotide (NADH), collagen, elastin and
lipids. The three consecutive decays were detected with a MCP-PMT having a rise
time of 150 ps (R3809U-50, Hamamatsu, Japan) and sampled with a high bandwidth
digitizer (1.5 GHz, 4 GS/s). Further details on FLIM sub-system characterization can
be found in [29].
3.1.2 OCT Sub-system
The FD-OCT sub-system used a 830 nm (40 nm bandwidth) superluminescent
light emitting diode (SLED) (EXS8410-2413, Exalos, Langhome, PA) as the light
source, providing an axial resolution of 7.6µm (in air). Light from the SLED was
directed to a 2×2 optical fiber coupler through a single-mode fiber where it gets
split into the reference and sample arms. The reflected beam from a reference mir-
ror and the backscattered light from the sample are recombined at the fiber cou-
pler and the spectral interferogram were obtained using a custom designed grating
based high speed spectrometer (1200 L/mm, Wasatch Photonics, Logan, UT; band-
width: 102 nm; line rate of up to 59 kHz) and and a CCD linescan camera (Aviiva,
SM2CL1014, EV2 Technologies, Essex, England). The detected signal was digitized
and acquired using a high speed imaging acquisition board (PCIe-1427, National
Instruments, Austin, TX). The OCT subsystem had a signal-to-noise ratio (SNR) of
98 dB and a 3 dB single sided fall-off of 900µm.
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3.1.3 Common Path
The OCT sample beam and FLIM excitation were combined via a dichroic mirror
(DM1) (reflects UV and transmits visible-near IR light). Beam scanning over a field
of view of 2×2 mm2 (corresponding to 600×600×1024 (x×y×depth) pixels for OCT
and 60× 60× 768 (x× y× time) pixels for FLIM) was achieved using a set of galvo
mirrors (6230H, Cambridge Technology, Lexington, MA). A broadly achromatic (UV-
near IR) objective lens (5X/0.16 NA, EC plan-Neufluar, Zeiss, Germany) was used
to simultaneously focus the OCT and FLIM excitation beams resulting in lateral
resolutions of 13.4µm for OCT and 100µm for FLIM. The OCT and FLIM emission
beams were separated by using a second dichroic mirror (DM2), which transmitted
the near-IR OCT beam and reflected the UV-visible FLIM beam.
3.1.4 System Control and Data Processing
An OCT/FLIM data acquisition module was developed in Labview (Labview 8.6,
National Instruments, Austin, TX) to control the electronics, data acquisition and
imaging. 3-D multi-spectral FLIM datasets and co-registered OCT volumes were
acquired using a galvo mirror arrangement and was saved on a host computer for
post-processing. Due to the low pulse energy of the FLIM excitation beam (maximum
of 240 nJ at 10 KHz), 20 tissue autofluorescence decays were averaged to improve the
SNR.
29
3.2 Tissue Datasets
We present below a brief description of the tissue databases used for data analysis
in this dissertation and the imaging protocol thereof. The two databases, namely, the
arterial tissue database and the hamster cheek pouch tissue database were used in the
studies relating to atherosclerosis and oral cancer, respectively. Specific details about
the histopathological findings will be discussed in the context of the data analysis
presented in the relevant sections, later in the dissertation.
3.2.1 Coronary Artery Tissue Database
Human coronary artery segments were obtained from 6 autopsy cases within 48
hours of the time of death, according to a protocol approved by the Texas A&M
University Institutional Review Board. A total of 58 arterial segments were lon-
gitudinally opened and imaged from the lumen side. Immediately after imaging,
each segment was ink marked (for correlation with histopathology), fixed in 10%
formalin, and sent for histopathology analysis for which each imaged plaque segment
was consecutively sectioned every 500µm. The sections were stained with Movat
pentachrome and evaluated by a cardiovascular pathologist.
3.2.2 Hamster Cheek Pouch Tissue Database
The standard Syrian golden hamster (mesocricetus auratus) cheek pouch model of
epithelial cancer was used in this study. The animal protocol consisted of scheduled
application of a suspension of 2.0% Benzo[a]pyrene (Sigma Aldrich Corporation, St
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Louis, Missouri) in mineral oil to the right cheek of 20 hamsters three times per week
for up to 32 weeks. 11 control animals were similarly treated with mineral oil alone.
The procedure was approved by the Institution for Animal Care and Use Commit-
tee at Texas A&M University. Before imaging, the hamsters were anaesthetized by
administering a mixture of ketamine and xylazine The cheek pouches of the anaes-
thetized animals were inverted and positioned under the microscope objective of the
imaging system. After imaging, the animal was euthanized by barbiturate overdose.
Biopsy samples from the imaged areas were processed following standard procedures
for histopathology analysis (H&E staining) by a board certified pathologist.
31
4. NOVEL AUTOMATED LAGUERRE DECONVOLUTION*
4.1 Deconvolution in the Context of Time-Domain FLIM
As discussed in Section 2.2, in the context of time-domain FLIM, the recorded
decay at a given pixel of the FLIM image can be mathematically modeled as a con-
volution of the excitation pulse and the true fluorescence decay. In the following
discussion, we shall refer to the excitation pulse as the instrument response, and the
true fluorescence decay as the Impulse Response Function (IRF). To estimate the
IRF, therefore, the instrument response needs to be deconvolved from the recorded
fluorescence decay at each pixel of the image. Estimating the instrument response is
a problem in itself, which can be tackled in several ways [30]: (1) the instrument re-
sponse can be approximated by the measured fluorescence decay from a sample with
extremely short lifetime; (2) the instrument response can be indirectly obtained by
measuring the fluorescence decay of a reference compound with known IRF; or (3)
the instrument response is modeled as a pulse of certain amplitude and width. In the
present research, we have used a representative Gaussian profile to model the instru-
ment response. The most commonly used deconvolution technique for FLIM is the
non-linear least-squares iterative reconvolution method [31]. This method models the
IRF as a multi-exponential function and iteratively estimates the model parameters
*Reprinted, with permission, from P. Pande and J. Jo, “Automated Analysis of Fluorescence
Lifetime Imaging Microscopy (FLIM) Data Based on the Laguerre Deconvolution Method,” IEEE
Transactions on Biomedical Engineering. c©2011 IEEE, vol. 58, no. 1, pp. 172–181, 2011.
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(lifetimes and coefficients for the exponential terms) by a non-linear least squares
optimization technique. There are, however, some limitations of this method. First,
model selection in terms of the number of exponentials needed to correctly estimate
the IRF requires a priori knowledge about the nature of the decay, or trying out
different multi-exponential models (e.g. single-exponential, bi-exponential, and so
on) and choosing the one that minimizes a certain error criterion, (e.g. chi-squared
test) [22]. Secondly, the iterative process demands computation of a large number of
convolutions per pixel, which is time consuming and impractical for real-time FLIM
applications. Lastly, it requires large number of data samples, which increases the
acquisition time. Recently, Lee and French et al. [32] proposed the use of a stretched
exponential function: I(t) = I0e
(−t/τ)β , to model the IRF. This approach is more
flexible than the multiexponential formulation in that it can model a complex decay
as a weighted sum of exponentials where the parameter, β, is related to the proba-
bility distribution of decay times, thereby providing a much more general form for
IRF modeling than the multi-exponential models. However, since the model param-
eters, β and τ , have to be estimated through non-linear least-squares optimization,
this method is also computationally expensive and impractical for real-time FLIM
applications.
A novel deconvolution method for FLIM data analysis based on the Laguerre
expansion technique was recently introduced and validated [33, 34]. In this method,
the IRF at each pixel of the FLIM image is expressed as a linear combination of
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Laguerre basis functions with unknown coefficients. Estimating IRFs, then, amounts
to finding the expansion coefficients (the weights of the Laguerre basis functions) at
each pixel. The orthogonality of the Laguerre basis functions permits an extremely
efficient least-squares estimation of the Laguerre coefficients. Since estimation of the
expansion coefficients for all image pixels are performed simultaneously, this method
performs orders of magnitude faster than other algorithms. Accurate performance of
this method, however, depends on proper selection of the set of orthonormal Laguerre
basis functions, defined by a parameter called the Laguerre parameter and denoted
by α. In the original Laguerre FLIM deconvolution implementation, α is selected
using a trial and error approach, making it unsuitable for real-time applications. In
this section, we present a fully automated implementation of the Laguerre FLIM
deconvolution, whereby the Laguerre parameter, α, is treated as free parameter
within a nonlinear least-square optimization scheme.
4.2 Laguerre Deconvolution
In the context of time-domain FLIM, the series of time-gated fluorescence inten-
sity maps H(r, n) are given by the convolution of the IRF h(r, n) with the instrument
response x(n):
H(r, n) = T
K−1∑
m=0
h(r,m)x(n−m), (4.1)
where, r denotes the pixel number, n = 0, 1, . . . , N denotes the time gate, K deter-
mines the extent of system memory, T is the sampling interval, and N is the number
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of time samples per pixel [34]. The Laguerre deconvolution technique uses a set of
Discrete Laguerre Functions (DLF) as the orthonormal basis to represent the IRF:
h(r, n) =
L−1∑
j=0
cj(r)b
α
j (n), (4.2)
where, cj(r) are the unknown Laguerre Expansion Coefficients (LEC) at the rth
pixel, L is the number of DLFs (or the order of Laguerre basis) used to model the
IRF, and bαj (n) denotes jth order DLF [34], defined as:
bαj (n) = α
(n−j)/2(1− α)1/2
j∑
k=0
(−1)k
(
n
k
)(
j
k
)
αj−k(1− α)k (4.3)
The Laguerre parameter (0 < α < 1) determines the rate of exponential decline of
the DLFs and defines the time scale for which the Laguerre expansion of the system
IRF is most efficient in terms of convergence [35]. For a given pixel, the measured
fluorescence decay y(r, n) can thus be written as:
y(r, n) = H(r, n) =
L−1∑
j=0
cj(r)v
α
j (n), (4.4)
where,
vαj (n) = T
K−1∑
m=0
bαj (m)x(n−m). (4.5)
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Then, the system of linear equations defined in Eq. (4.4) can be expressed in matrix
notations as follows:

y(r, 0)
y(r, 1)
...
y(r,N − 1)

︸ ︷︷ ︸
yr
=

vα0 (0) v
α
1 (0) · · · vαL−1(0)
vα0 (1) v
α
1 (1) · · · vαL−1(1)
...
...
. . .
...
vα0 (N − 1) vα1 (N − 1) · · · vαL−1(N − 1)

︸ ︷︷ ︸
Vα

c0(r)
c1(r)
...
cL−1(r)

︸ ︷︷ ︸
cr
or, equivalently,
yr = Vαcr. (4.6)
To include the effect of experimental noise, we modify Eq. (4.6) as:
yr = Vαcr + r, (4.7)
where, r is the error vector resulting due to noise at the rth pixel.
4.3 Automated Laguerre Decomvolution
The objective of deconvolution is to obtain the IRF, or, equivalently, the LEC
vector cr in Eq. (4.7). The correct estimation of LEC depends on proper selection
of the set of DLFs, which in turn depends on proper choice of Laguerre parameter
α. Equation (4.7) can be solved to get the least-squares estimate of the measured
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decay yr, which is equal to:
yˆr = Vα
(
VTαVα
)−1
VTαyr. (4.8)
4.3.1 Defining and Optimizing the Cost Function
The cost function at the rth pixel can then defined as the mean squared error
(MSE) of the estimated decay:
F r(α) = (yr − yˆr)T (yr − yˆr)
= yTr (I−Vα
(
VTαVα
)−1
VTα)yr
= yTr (y
T
r − yˆT r)
= yTr r.
(4.9)
It must be reiterated that all the analysis so far focused on one pixel of the FLIM
image. If we denote the number of pixels in a FLIM image by M , then, the cost
function for the entire FLIM image can be written as a sum of the MSE computed
for each pixel of the image:
Fimage(α) = F
1(α) + F 2(α) + · · ·+ FM(α). (4.10)
Our objective is to find the value of α that minimizes the cost function defined in
Eq. (4.10). We denote this optimum value of α by αˆ . Mathematically, this problem
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can be stated as:
arg max
α
Fimage(α). (4.11)
The problem stated in 4.11 can be framed as a nonlinear least-squares optimization
problem. Since α is constrained in (0, 1), we implemented a simple iterative gradient
based optimization scheme, where the search direction and step size γ was determined
using successive bisection algorithm. This iterative process can be summarized as:
αˆv+1 = αˆv − γv
[
d
dα
(Fimage(α))
]v
(4.12)
Here, αˆv and γv denote the estimated value of α and the step size at vth iteration.
Next, we find an expression for the derivative of the cost function. Here, we briefly
outline the method of obtaining such an expression. For a more detailed derivation,
interested readers are referred to [36], wherein a similar expression was derived for
time resolved fluorescence spectroscopy measurements. It follows from Eq. (4.9) and
Eq. (4.10) that:
d
dα
(Fimage(α)) =
M∑
r=1
yTr
(
dr
dα
)
. (4.13)
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If we define two matrices Ymodified and Emodfied as:
Ymodified =

y(0, 1) y(1, 1) · · · y(N − 1, 1)
y(0, 2) y(1, 2) · · · y(N − 1, 2)
...
...
. . .
...
y(0,M) y(1,M) · · · y(N − 1,M)

T
(4.14)
Emodified =
[
d1
dα
d2
dα
· · · dM
dα
]T
(4.15)
It can be shown that each term of the summation in Eq. (4.13) corresponds to a
diagonal term of the matrix product YTmodifiedEmodified. It then follows that the
summation in the right hand side (RHS) of Eq. (4.13) can be written as:
d
dα
(Fimage(α)) = trace
(
YTmodifiedEmodified
)
(4.16)
To evaluate Emodified, we define another matrix Cmodified as:
Cmodified =

c0(1) c0(2) · · · c0(M)
c1(1) c1(2) · · · c1(M)
...
...
. . .
...
cL−1(1) cL−1(2) · · · cL−1(M)

. (4.17)
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Following the derivation in [36], we can write an expression for Emodified as:
Emodified =
dVα
dα
Cmodified + Vα(V
T
αVα)
−1[
dVTα
dα
Ymodified −
(
dVTα
dα
Vα + V
T
α
dVTα
dα
)
Cmodified
]
.
(4.18)
Finally, to evaluate dVα
dα
and dV
T
α
dα
we use the recursive property of the DLF [35],
which gives:
dvαj
dα
=
1
2
√
α
(
vαj (n− 1) + vαj−1 (n)
)
+
√
α
(
dvαj (n− 1)
dα
+
dvαj−1 (n)
dα
)
− dv
α
j−1 (n)
dα
(4.19)
where,
dvα0
dα
=
1
2
√
α
(vα0 (n− 1)) +
√
α
(
dvα0 (n− 1)
dα
)
+
1
2
√
1− αx(n). (4.20)
Using Eq. (4.16) - (4.20) in Eq. (4.12), we can estimate the optimal value of α. For
the analyses presented in the next section, we fixed the order of Laguerre expansion
basis to 4, based on findings from previous studies [36].
4.4 Instrumentation for FLIM Measurements
The FLIM imaging was accomplished using a time-domain wide-field time-gated
endoscopic FLIM instrument [37]. The central component of the FLIM system was
an intensified CCD camera (4Picos, Stanford Computer Optics) coupled to a flexible
endoscope through a microscope objective (20×). The endoscope was constructed
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from a 10,000 fiber coherent bundle (O.D. 400µm) glued to a GRIN lens (NA 0.5,
4 mm working distance). Light pulse excitation was delivered via a multimode fiber
(NA 0.22). A filter wheel inserted in the collimated optical path was used for multi-
spectral imaging at the predefined emission bands of 390± 20, 450± 20, and 550± 40
nm. A N2 UV laser (337 nm, 0.8 ns FWHM, 50 Hz repetition rate, 5µJ/pulse) was
used for excitation. The FLIM images were acquired with a time resolution of 200 ps.
4.5 Method Validation on Synthetic and Experimental FLIM Data
The performance of the proposed algorithm was tested on: (i) synthetic FLIM
data, (ii) experimental FLIM data from fluorescence lifetime standards, and (iii)
experimental FLIM data from biological tissue.
4.5.1 Synthetic FLIM Images
A synthetic FLIM image (25 X 25 pixels) was generated using a bi-exponential
model (lifetimes 1 ns and 4 ns) with relative contributions varying in a linear fashion
(from 1 ns at the lower rightmost to 4 ns at the top leftmost pixel). Additive white
noise was added to yield two images at 40 dB and 25 dB SNR. A representative
Gaussian profile for instrument response was used to generate the synthetic FLIM
images. Fig. 4.1 (a) shows the theoretically calculated lifetime map. For a mixture
of two fluorophores of relative contribution β, (0 ≥ β ≤ 1) and (1− β), and lifetime
τ1 and τ2, respectively; the average lifetime of the mixture is given by [22]:
τmixture =
βτ 21 + (1− β)τ 22
βτ1 + (1− β)τ2 (4.21)
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Figure 4.1: Validation results on synthetic data. (a) Theoretically calculated life-
time map. (b) Estimated lifetime map at 40 dB SNR. (c) Estimated lifetime map
at 25 dB SNR. (d) Measured decay at a sample pixel and the estimated fit. Also,
shown is the instrument response, estimated IRF and the error residuals. (e) Cor-
relation between the true and estimated lifetime values at 25 and 40 dB SNR. The
green and blue curves correspond to lifetimes estimated after deconvolution for 25
and 40 dB, respectively. The red curve corresponds to lifetimes estimated without
deconvolution by simply fitting a bi-exponential model to the decaying part of the
measured fluorescence signal (at 40 dB only).
The synthetic data was then deconvolved using the proposed deconvolution algorithm
to estimate the IRF and thereafter the average lifetime map (as defined in Eq. (2.4))
was calculated from the estimated IRFs. Optimal value of α was found to be 0.829
and 0.834 for 40 dB and 25 dB noise levels, respectively. In Fig. 4.1 (d), we plot the
measured decay, the instrument response profile (labelled laser), and the estimated
decay for a representative pixel in the FLIM image. In order to assess the goodness of
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fit of our model, we calculate the residual of the fit, normalized against the maximum
value of the recorded decay. The magnitude of the residual was found to be <1%
and it showed a random behavior suggesting that the model fits the data well. This
was further validated by calculating the autocorrelation of the residual. Since, in the
absence of any systematic errors, the residual is randomly distributed around zero,
we would expect its autocorrelation function to die down to zero very rapidly, as
shown in the autocorrelation inset of Fig. 4.1 (d). The estimated lifetime maps at
40 dB and 25 dB SNR are shown in Fig. 4.1 (b) and Fig. 4.1 (c), respectively. Both the
estimated lifetime maps were similar to the true lifetime map; however, as expected,
the variability in the estimated lifetime values was more in the low SNR condition.
The correlation plot between the true (theoretical) and estimated lifetimes for
both 25 dB (green) 40 dB SNR (blue) shown in Fig. 4.1 (e) suggests good lifetime
estimation by the proposed method. To illustrate the importance of deconvolution,
we also estimated the lifetimes by using a bi-exponential model fit to the decaying
part of the measured fluorescence decay as a surrogate for the IRF. This approach
of lifetime estimation is implemented in many commercially available software for
FLIM data analysis. The correlation plot for the true and lifetimes estimated in this
manner (without deconvolving) is also shown in Fig. 4.1 (e) (red curve) for 40 dB
SNR. The relatively poor correlation between the two lifetimes, emphasizes the need
for deconvolution.
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Figure 4.2: Validation results on FLIM images of standard fluorophores. Three
fluorophores (POPOP, NADH, FAD) were loaded on quartz capillaries and imaged
with our FLIM system. (a) The normalized intensity maps at 390 nm, 450 nm
and 550 nm emission bands correctly reflect the emission spectrum of the three
fluorophores. (b) The lifetime map shows accurate estimation of each fluorophore
lifetime characteristics. (c) Lifetime histogram indicates that the three fluorophores
can be identified directly from the estimated lifetime map.
4.5.2 Validation on Fluorescence Lifetime Standards and Endogenous Fluorophores
Validation of the proposed algorithm on fluorophores with known emission spectra
and lifetimes was done in two different ways.
Experiment 1: The fluorophores used for validating our method were selected to
cover a broad range of emission wavelengths (380–600 nm) and fluorescence lifetimes
(0.4–12 ns). These included two exogenous flurophores: Rhodamin B (RhB) (25242,
Sigma-Aldrich) and 9-cyanoanthracene (9CA) (15276, Sigma-Aldrich) dissolved in
ethanol to a concentration of 1µM and two endogenous fluorophores, relevant for
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potential fluorescence based tissue diagnosis [38, 39]: Nicotinamide Adenine Dinu-
cleotide (NADH) (N8129, Sigma-Aldrich) and Flavin Adenine Dinucleotide (FAD)
(F6625, Sigma-Aldrich) dissolved in Phosphate Buffered Saline (PBS) to a concen-
tration of 1µM. The solutions were placed in a quartz cuvette and illuminated from
one side of the cuvette, while the endoscope was positioned on the other side of
the cuvette for imaging. For each sample, FLIM images corresponding to the peak
emission band of that fluorophore were recorded. The laser pulse energy at the tip
of the excitation fiber probe was adjusted to ∼5µJ/pulse.
Experiment 2: The idea behind performing the second experiment was to
demonstrate the robustness of the proposed deconvolution scheme, in terms of its
ability to estimate IRFs having different decay rates (lifetimes) using the same value
of α. This is of particular importance in tissue imaging applications, where different
tissue regions may have different biochemical compositions (e.g. a malignant region
surrounded by a normal region), thereby resulting in IRFs with different decay rates.
For this experiment, we obtained a single FLIM image for three different fluorophores
namely, FAD, NADH and POPOP [p-phenylenbis(5.-phenyl-2.-oxazol)]. Solutions of
POPOP in Methanol, and NADH and FAD in PBS (1µM concentration each) were
prepared and loaded in quartz capillaries (400µm diameter) for FLIM imaging. All
other experimental conditions were identical to those described in the first experi-
ment. The performance of the proposed deconvolution algorithm was evaluated by
estimating a global value of α for the entire image and comparing the known lifetime
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Table 4.1: Validation results from fluorescence standards and tissue endogenous
fluorophores FLIM data(Laguerre order equals 4) from fluorescence standards and
tissue endogenous fluorophores FLIM data
Sample Wavelength C.F.a Optimal Lifetime (ns) Computational
(solvent) (nm) α Estimated Literature Time(s)
9CA
450± 40 1 0.953 11.92± 0.28 11.70–12.28 211.6
(Ethanol) 3 0.953 37.6
RhB
550± 80 1 0.732 2.49± 0.08 2.60–3.01 44.4
(Ethanol) 3 0.730 8.5
FAD
550± 80 1 0.788 2.61± 0.11 2.30–2.85 48.6
(PBS) 3 0.788 8.9
NADH
450± 40 1 0.265 0.31± 0.11 0.30–0.50 7.1
(PBS) 3 0.263 1.4
aC.F. stands for Compression Factor as discussed in Section 4.6
values of three fluorophores with the lifetimes calculated from the IRFs obtained
after deconvolution.
Results from the analysis of FLIM images of fluorescence lifetime standards and
endogenous fluorophores, as described in Experiment 1, are summarized in Table 4.1.
As mentioned earlier, Laguerre order expansion was fixed to four to estimate the flu-
orescence IRF in all cases. It was found that the optimal values of α were correlated
with the fluorescence lifetimes: short-lived decays were expanded with smaller values
of α (α = 0.265 for NADH with τ = 0.31 ns), while longer decays required larger α
values (α = 0.953 for 9CA with τ = 11.92 ns). The lifetime maps (not shown here),
showed a homogeneous spatial distribution of lifetimes. Histograms of the lifetime
maps (not shown here) for all four lifetime standards were Gaussian with mean and
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standard deviation values as reported in Table 4.1. The mean lifetime values reported
in Table 4.1 are in good agreement with those obtained from spectroscopy measure-
ments of the same fluorescent standard solutions with a time-resolved fluorescence
spectroscopy system, as previously reported [40].
Validation results from this experiment are shown in Fig. 4.2. The normalized
intensity maps at 390 nm, 450 nm and 550 nm emission bands are in accordance
with the emission spectrum of the three fluorophores: the POPOP capillary showed
emission at both the 390 nm and 450 nm bands, the NADH capillary showed the
strongest emission at the 450 nm band, and the FAD capillary showed significant
emission only the 550 nm band. Optimal value of α in this case was found to be
0.694. The lifetime values for the three fluorophores are also in good agreement with
the values reported in the literature: the POPOP capillary showed a homogenous
lifetime map with values ∼1.4 ns, the NADH capillary showed a homogenous lifetime
map with values ∼0.5 ns, and the FAD capillary showed a homogenous lifetime map
with values ∼2.3 ns. The histogram of the lifetime values indicate that the three
fluorophores can be identified from their estimated lifetime values. Moreover, lifetime
values estimated for NADH and FAD in this experiment are in good agreement with
the values obtained in Experiment 1.
4.5.3 Validation on Biological Tissue Autofluorescence
The automated Laguerre deconvolution method was also tested on FLIM mea-
surements obtained from biological tissue. A postmortem human coronary artery
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Figure 4.3: Analysis of FLIM images of a fibrotic plaque in human artery. (a) The
plaque histopathology showing a thick fibrotic (F) collagen-rich plaque in the middle
region of the arterial section (blue solid curved line), and a thinner (T) elastin and
collagen-rich region towards the bottom side of the section (red solid curved line).
(b) Normalized intensity and lifetime maps (top and bottom respectively) at 390 nm
and 450 nm. (c) Normalized spectra and (d) lifetime values of collagen and elastin
obtained from time-resolved fluorescence spectroscopy measurements.
was harvested from an autopsy case. The coronary artery was opened longitudinally
for luminal imaging. The coronary plaques were imaged by placing the endoscope
tip perpendicular to the lumen side, resulting in a circular field of view of ∼2 mm.
The laser pulse energy at the tip of the excitation fiber probe was also adjusted to
∼5µJ/pulse. The FLIM images from the coronary artery showing an atherosclerotic
plaque are shown in Fig. 4.3. The artery histopathology (corresponding to a per-
pendicular section cut through the center of the FLIM field of view) showed a thick
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fibrotic (F) collagen-rich plaque in the middle region of the arterial section (blue solid
curved line), and a thinner (T) elastin and collagen-rich region towards the bottom
side of the section (red solid curved line) as shown in Fig. 4.3 (a). Both the normal-
ized intensity and lifetime maps showed two different regions (Fig. 4.3 (b)): a middle
one (F) correlated to the fibrotic region and a bottom one (T) correlated to the thin-
ner plaque. The contrast, however, was more dramatic for the 390 nm emission band.
The normalized intensity at 390 nm was ∼60% for the middle (F) region and ∼40%
for the bottom (T) region. On the other hand, the normalized intensity at 450 nm
was smaller for the middle (F) region (∼30%) compared to the bottom (T) region
(∼40%). The fluorescence lifetime at 390 nm was longer (∼3 ns) for the middle (F)
region compared to the bottom (T) region (∼2 ns). On the other hand, the lifetime
at 450 nm was in the range 1.5–2 ns for both regions. The intensity and lifetime maps
at 550 nm (not shown) did not show any difference between the two regions, and were
therefore not shown in Fig. 4.3. To correlate the artery fluorescence emission with
those from purified collagen and elastin extracts, time-resolved fluorescence measure-
ments of collagen and elastin were recorded and analyzed. The normalized spectra
and lifetimes for the two fluorophores are also shown in Fig. 4.3 (c) & (d). The flu-
orescence spectra (normalized against the area under the curve) showed that the
relative fluorescence intensity of collagen at in 390–400 nm range is almost twofold
than that of elastin; while the relative fluorescence emission of elastin at 450 nm is
almost 50% stronger than that of collagen. The fluorescence lifetime of collagen was
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in the range of 2.5–3 ns for the entire emission spectrum; while for the lifetime in-
creased from about 1.3 ns in the 390–400 nm range to almost 2 ns at 450 nm. Based
on these characteristics, it was concluded that the thick plaque reflected the fluores-
cence emission of collagen, while the FLIM signal of the thinner part of the plaque
reflected the fluorescence emission of both elastin and collagen.
4.6 Computational Performance
An important aspect of the present study that needs attention is the fact that a
significant reduction in computation time could be achieved by compressing the the
FLIM image (or FLIM data volume, to be more precise) without compromising the
accuracy in the value of optimal α, as reported in Table 4.1. A compression factor
(C.F.) of N means that the measured decays in a N×N region in FLIM data volume
is replaced by a single decay equal to the average of all the replaced recorded decays
(thus, a C.F of 1 would mean no compression). It was found that a compression
factor of 3 applied to reduce the image size and speed up the optimization algorithm
did not affect the estimation of the optimal values for α, while significantly reducing
the computation time. Also, the computation time for 9-Cyanoanthracene (9CA)
was much longer than for the other fluorophores. This is because the large lifetime
(∼11 ns) of 9CA demands an acquisition and processing of a larger sized FLIM data
as compared to fluorophores with relatively shorter lifetimes. It must be noted that
image compression is performed only to speed up the optimization of α. Once, we
have the optimal value of α, the deconvolution is then performed on the uncompressed
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image.
4.7 Conclusions
As stated in the introduction, the recorded decay at a given pixel of the FLIM
image is mathematically modeled as a convolution of the instrument response with
the IRF of the sample at that pixel. Thus, to estimate the IRF, the instrument
response needs to be deconvolved from the recorded fluorescence decay at each pixel
of the image. Accurate deconvolution becomes even more important when the width
of the instrument response is comparable to the lifetime of the fluorescent sample.
This observation was also clear from the results presented in Fig. 4.1 and Table 4.1,
where we compared the lifetime estimates obtained through deconvolution against
the case when no deconvolution was performed.
The proposed automated Laguerre deconvolution technique was successfully tested
on a set of synthetic FLIM images covering a range of lifetime values (1–4 ns) de-
rived from a bi-exponential model. The chosen lifetime range was significant, since
a number of biologically relevant fluorophores have lifetimes in this range. The ro-
bustness of the proposed deconvolution method was demonstrated by its ability to
accurately retrieve the IRFs at every pixel of the synthetic FLIM images covering
a broad dynamic range under moderate and high noise conditions (40 and 25 dB
SNR, respectively). The algorithm was also successfully tested on measured FLIM
images from fluorescence lifetime standards. The fact that the lifetime values ob-
tained by the Laguerre method for the fluorescence standards were very close to the
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values reported in the literature confirms the accuracy of our method. Moreover, the
results from the second experiment where multiple fluorescence lifetime standards
were imaged together, further demonstrated the ability of the proposed algorithm to
retrieve correct lifetime values from FLIM images that might have regions of different
intensities and lifetimes.
We also demonstrated the applicability of the proposed technique on FLIM data
obtained from a biological tissue. In this case, the proposed deconvolution algorithm
produced lifetime maps having two regions with significantly different lifetimes. The
lifetime values in the two regions, corroborated with the histopathological finding
that the two regions correspond to a collagen-rich thick fibrotic plaque section and
an elastin-rich thinner section of the plaque. This example has demonstrated the
capability of FLIM to distinguish regions of different endogenous fluorophores, sug-
gesting that it could be used as a potential optical technique in medical diagnosis.
Moreover, the fact that the proposed technique is fast and automated makes it suit-
able for not only ex-vivo studies but also for in-vivo applications.
An important aspect of the proposed algorithm is that it optimizes a global value
of the parameter α to fit a range of impulse response functions having different
decay rates. In [35], Marmerelis discussed the empirical relationship between the
optimal value of α and the memory of the nonlinear signal that is being estimated
using the discrete Laguerre basis. Based on this, the author proposed a rather
heuristic way of selecting the proper value of α for the estimation of nonlinear signals
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Figure 4.4: Plot showing the correlation between estimated and true lifetime values
for different values of α
based on Laguerre kernel expansion. In the context of the research presented in this
paper, the empirical relationship described in [35] translates to the fact that for
a given order, fluorescence decays having longer lifetimes require larger values of
α for proper representation within the Laguerre expansion framework; and decays
having relatively shorter lifetimes require smaller values of α. This relationship is
also evident from the lifetime and optimal α values presented in Table 4.1.
If one then extends this deduction to a case where it is required to estimate a set
of fluorescence decays characterized by different lifetimes using a single value of α
(which we have called the optimal α), a question that naturally arises is: how well do
we expect to estimate different lifetimes using the same value of α? To answer this
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question, let us reconsider the case where we validated the proposed algorithm on
synthetic data, where we had a FLIM image with lifetime values ranging from 1 ns
to 4 ns. The optimal value of α in this case was found to be 0.829 for a noise level of
40 dB. The correlation plot of the estimated vs. true lifetime for this optimal value
shown in Fig. 4.1(e) is reproduced in Fig. 4.4 (blue squares). To study the effect
of choosing a sub-optimal value of α for estimation of lifetimes, we deconvolved the
noisy synthetic data with a value of α = 0.780. The correlation plot for this value
of α is also shown in Fig. 4.4 (green circles). Next, to study the effect of choosing
a value of α that is greater than the optimal value, we perform the same process
of deconvolving and plotting the correlation plot for α = 0.870, which is shown in
magenta diamonds in Fig. 4.4. We also plot the ideal correlation plot as a black
solid line from 1 ns to 4 ns. It is clear from this plot that for a value of α greater
than the optimal α, higher lifetimes are estimated much more accurately than shorter
lifetimes (magenta diamonds); whereas for a sub-optimal value of α, shorter lifetimes
are estimated more accurately than larger lifetimes (green circles). For the optimal
α, we get an extremely accurate estimation of lifetime values around 2.8–3.2 ns. For
lifetime values lying outside this range one either side, the estimate gets worse but
stays confined within a small margin of 0.1 ns (shown as red broken line on either
side of the solid black line). This means that the error in lifetime estimation for
optimal value of α is at worse 0.1 ns for the entire range of 1–4 ns. The maximum
error in the case of choosing a sub-optimal α was 0.2 ns and 0.6 ns for α = 0.780 and
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Figure 4.5: Results of the simulation study to test the lifetime dependence of the α
parameter. (a) & (b) shows lifetime estimates for mixture 1a and 1b (not respec-
tively). Blue histograms correspond to mixture 1a and red histograms correspond to
mixture 1b. (d) & (c) shows lifetime estimates for mixture 2a and 2b, respectively.
Blue histograms correspond to Mixture 2a and red histograms correspond to Mixture
2b. Black dotted line denotes the true lifetime value.
0.870, respectively. Thus, the best value of α = 0.829 is optimal in a sense that it
gives a reasonable error (maximum error ∼0.1 ns) in estimating the lifetimes over a
range of lifetime values, which is smaller than that obtained for any other value of
α.
The question that follows next is: how much error in lifetime estimates is ac-
ceptable? The answer is that in most applications where we one is interested in
distinguishing different fluorophores based on their lifetime values, it depends on the
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individual lifetimes of the constituent species as well as the range of the lifetime
values. For example, in the case of the artery sample, the constituent fluorophores,
collagen and elastin showing average lifetimes of ∼3 ns and ∼2 ns, respectively, in
the 390 nm band, could be easily distinguished within a tolerance of 0.1 ns.
To study the sensitivity of α on relative concentration of constituent fluorophores
and their lifetime, we perform a simple simulation study, where we simulate fluores-
cence decay maps for 4 different mixtures at 40 dB SNR, namely:
Mixture 1a 20% of τ = 1 ns; 80% of τ = 4 ns
Mixture 1b 20% of τ = 4 ns; 80% of τ = 1 ns
Mixture 2a 20% of τ = 1 ns; 80% of τ = 7 ns
Mixture 2b 20% of τ = 7 ns; 80% of τ = 1 ns
Since the cost function for α optimization is defined as the sum of cost functions
for each pixel (see equation 4.10). We expect the estimation of α to be biased towards
the component present in majority. Through simulations we find that it is indeed
the case. Fig. 4.5 below shows the histograms of the estimated lifetimes for each of
the 4 mixtures described above.
Several interesting observations can be made from this simulation study. Since
every mixture above contains two lifetime components, the estimated lifetime of each
component is biased in a way such that the lower lifetime is overestimated and the
higher lifetime value is underestimated. Note that for mixture 1b, where the 1 ns
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component is present in majority, bias in the lifetime estimation is smaller than the
bias when the 1 ns component is in minority, as in mixture 1a (red histogram is less
biased than blue histogram in Fig. 4.5 (a)). Similarly, for mixture 1a, where the 4 ns
component is present in majority, the bias in lifetime estimation is smaller than the
bias when the 4 ns component is in minority, as in mixture 1b (blue histogram is less
biased than red histogram in Fig. 4.5 (b)). Same trend is observed for mixtures 2a
and 2b where the lower and higher lifetime components have values 1 ns and 7 ns,
respectively. This is shown in Fig. 4.5 (c)&(d). Moreover, bias in lifetime estimation
in the case of mixtures that have widely spaced lifetime values are much higher than
biases for mixtures where the lifetime values of the constituent species are not too
widely spaced, i.e. bias in case of 1 ns and 7 ns mixture is more than the bias in case
of 1 ns and 4 ns mixture. It is thus clear from these observations that the range of
lifetime values of different species present in a mixture is more important than their
relative proportions to decide whether the same value of α should be used for the
entire mixture or should different regions of possibly different lifetimes be analyzed
separately. It should be noted that the range 1–7 ns was used only for simulation
purpose and that for most practical applications like tissue imaging, the range of
lifetime values is not so wide and thus a single value of α would generally suffice.
Our validation results on FLIM data from fluorescence lifetime standards and tis-
sue endogenous fluorophores show that the proposed algorithm is capable of finding
an optimal value of α using non-linear least square optimization, which is then used
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to find the optimal IRFs by estimating the LECs using linear least-squares approach.
This is a significant improvement over previous implementation of the Laguerre de-
convolution method, in which the values of α was determined by trial and error. The
automated algorithm, however, takes more machine time than the standard Laguerre
deconvolution method. This is not surprising, though, since the proposed algorithm
performs an additional task of optimizing α as opposed to the standard Laguerre
deconvolution that relies on a user provided value of α to perform the deconvolu-
tion. If computational time is a major concern for certain application, a significant
improvement in speed can be achieved by performing the optimal search for α on a
compressed FLIM data volume rather than the original uncompressed data, as dis-
cussed in an earlier section. The bottom line is that the optimization of α ensures
an accurate and automated estimation of fluorescence IRFs. The proposed method
thus offers an opportunity to perform an automated analysis of FLIM data and will,
therefore, facilitate the use of FLIM in applications requiring minimal user interven-
tion, such as in-vivo tissue imaging for clinical diagnosis. Also, because Laguerre
basis functions have been used to model a wide variety of phenomena and systems,
particularly in the areas of system identification [41,42] and control theory [43], the
application of the presented method is not limited to FLIM alone but to a wider
variety of problems.
58
5. APPLICATION OF NON-NEGATIVE MATRIX
FACTORIZATION TO MULTISPECTRAL FLIM DATA
ANALYSIS*
5.1 Introduction
Despite several studies showing the potential of multispectral FLIM as a promis-
ing clinical optical imaging modality [44–47], its utility has not yet been fully es-
tablished. One of the main reasons for this is the element of subjectivity involved
in interpreting multispectral FLIM images. Existing methods of interpreting mul-
tispectral FLIM images are based on a qualitative comparison of spectral intensity
and lifetime values at each pixel in a FLIM image with those of known fluorophores.
Such comparison-based interpretation of FLIM images is satisfactory only when the
fluorescence decay at each pixel can be attributed to primarily just one fluorophore.
However, in most practical applications, there are often more than one fluoresc-
ing species contributing to the bulk fluorescence signal. In such cases, it becomes
imperative to develop a method that can quantitatively characterize the type and
relative abundance of fluorophores present in a sample. This is of particular interest
*Parts of this section have been reprinted, with permission, from:
1. P. Pande, B. E. Applegate, and J. Jo, “Application of non-negative matrix factorization to
multispectral FLIM data analysis,” Biomedical Optics Express, vol. 3, no. 9, pp. 2244–2262,
2012. c©2012 OSA
2. J. Park, P. Pande, S. Shrestha, F. Clubb, B. E. Applegate, and J. A. Jo, “Biochemical
characterization of atherosclerotic plaques by endogenous multispectral fluorescence lifetime
imaging microscopy,” Atherosclerosis, vol. 220, no. 2, pp. 394–401, 2012. c©2012 Elsevier
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in the context of biomedical diagnosis, since the progression from normal to patho-
logical tissue is often characterized by changes in the relative abundance of tissue
fluorophores.
Several studies reported in the literature that attempt to quantify the contribu-
tions of constituent fluorophores to bulk fluorescence signal, are based on lifetime
measurements [48, 49]. In the general approach, it is assumed that the constituent
fluorophores have mono-exponential decay dynamics with known lifetimes, and con-
sequently the mixture fluorescence dynamics is modeled as a multi-exponential decay,
wherein, each exponential component corresponds to a specific fluorophore. The
sample fluorescence decay at each pixel is thus fitted to the corresponding multi-
exponential model, and the estimated pre-exponential weights are used as surrogates
for the relative contributions of the constituent fluorophores to the bulk fluorescence
signal. When the lifetime values of the fluorophores are not known a priori, the
global analysis approach is applied, in which the global fluorophore lifetimes are also
estimated from the complete FLIM data [48].
Although generally used, these methods suffer from several limitations. First,
the assumption of mono-exponential decay for each fluorophore is quite often inac-
curate, since many exogenous and endogenous fluorophores show more complex decay
profiles. For instance, Flavin Adenine Dinucleotide (FAD), which is an important
cofactor in many enzymatic reactions, is known to have a non-exponential decay [22].
Similarly, for a single tryptophan protein, the distribution of protein conformations
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results in a complex decay profile [50]. Second, most of these methods are restricted
to two-component models [48,51]; thus, they can only handle data in which at most
two fluorescent species are being simultaneously monitored. These two major limi-
tations have been identified in a number of publications. In particular, Veerver et al.
have addressed these issues in [48], where the authors have stated that the “resolution
of fluorophores with complex decays and separation of more than two fluorophores
continues to be a topic of research”. Third, from a computational aspect, accurate
fitting of fluorescence decay data to a multi-exponential model requires signal-to-
noise levels that are in many cases impractical for FLIM measurements [22]. Fourth,
unless extremely short excitation light pulses are used, time deconvolution of the
instrument response from the fluorescence decay data is required prior to lifetime
estimation, which results in an additional computational burden. Lastly, all these
methods are applicable to single spectral channel FLIM data and are thus unable to
exploit the spectral information contained in the multispectral FLIM data [49,52].
In this study, we present the application of non-negative matrix factorization
(NMF) to multispectral FLIM data analysis. NMF is a multivariate data analysis
technique that aims at extracting non-negative signatures and relative contributions
of pure components from an additive mixture of those components; a process com-
monly referred to as unmixing [53]. In the context of FLIM data analysis, unmixing
amounts to expressing the bulk fluorescence signal obtained from a sample as a
weighted sum of fluorescence signals of the constituent fluorophores present in that
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sample, where the weights correspond to the relative contributions of the constituent
fluorophores to the bulk fluorescence signal. Unlike most other approaches men-
tioned earlier, which make assumptions about the functional form of the constituent
fluorophore decay profiles and are restricted to two-component models, NMF is able
to handle more than two fluorescent species showing complex decay dynamics (i.e.
non-monoexponential decay). Another significant advantage of the NMF based ap-
proach is that it can be directly applied to raw multispectral FLIM intensity data,
obviating the need to perform time-consuming deconvolution.
In the present study, the following two specific aims were accomplished. First, we
proposed a new set of features to characterize multispectral FLIM data. This feature
set (henceforth referred to as NMF FLIM features) comprises the relative abundance
of constituent fluorophores derived via NMF of multispectral FLIM data. We also
showed how these features are more intuitive and easy to interpret than the stan-
dard bulk intensity and lifetime features (henceforth referred to as standard FLIM
features), which are currently used to characterize multispectral FLIM data. Second,
we compared the performance of the NMF features against the standard FLIM fea-
tures in terms of their ability to discriminate between three types of atherosclerotic
plaques.
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5.2 Materials and Methods
5.2.1 FLIM Instrumentation
The coronary segments were imaged using an in-house built high speed bench-top
multispectral FLIM system reported in [29], and discussed in Section 3.1.1. Briefly,
the scanning FLIM system was implemented following a direct pulse-recording scheme,
in which the pixel rate could be equal to the laser repetition rate. A frequency tripled
Q-switched Nd:YAG laser was used as the excitation source (355 nm, 30 kHz max.
repetition rate, 1 ns pulse FWHM). The fluorescence emission was separated into
three spectral channels using a set of dichroic mirrors and filters (390± 20 nm for
collagen, 452± 22.5 nm for elastin, and 550± 20 nm for lipids). The emission from
each channel was launched into fibers with different lengths (1 m, 10 m and 19 m)
chosen to provide ∼45 ns interval between each emission band decay. The three con-
secutive decays were detected with a MCP-PMT (rise time: 150 ps) and sampled
with a high bandwidth digitizer (1.5 GHz, 4 GS/s). The system’s lateral resolution
was measured to be 100µm. Each multispectral FLIM image (FOV: 2×2 mm2 at
60×60 pixels) was acquired in ∼7 s.
5.2.2 Tissue Sample Preparation and Histopathological Evaluation
The coronary artery tissue database described in Section 3.2.1 was used in this
study. Based on the histopathological evaluation, each section was classified as: in-
timal thickening (IT), pathological intimal thickening (PIT), fibroatheroma (FA),
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thin-cap fibroatheroma (TCFA), calcified plaque (CA), and/or plaque with signif-
icant foam-cell (FC) infiltration [12]. A total of 21 segments showing similar and
uniform histopathological characteristics in all consecutive sections were selected
and grouped either as High-Collagen (HC; including FA and PIT), High-Lipids (HL;
including TCFA and PIT with significant foam-cell infiltration or FC-PIT) or Low-
Collagen/Lipids (LCL; including IT and CA). We shall refer to these datasets as the
homogeneous datasets while the remaining 37 datasets shall be called the heteroge-
neous datasets.
5.2.3 Multispectral FLIM Data in NMF Framework
Before setting out to describe the problem statement, the following notations are
in order. We shall denote the multispectral fluorescence intensity decay measured at
a given pixel (x, y) as a function of time (t) and wavelength band (λi) by I(x, y, t;λi).
If we linearly index, say N pixels in a multispectral FLIM image as i = 1, 2, . . . , N ,
such that the i th index corresponds to the pixel (x, y), and if we denote the spectro-
temporal FLIM profile at the ith pixel by xi, then we define this spectro-temporal
decay as a concatenation in time of the fluorescence decays for all emission bands; i.e.,
xi ≡ I(x, y, t;λ1, λ2, . . . , λP ) = [ I (x, y, t;λ1) , I(x, y, t;λ2), . . . , I(x, y, t;λP ) ], where
P denotes the number of emission bands. Let us also assume that in a sample
there are K fluorophores, termed end-members having multispectral time resolved
fluorescence decays denoted by sk ∈ RT , for k = 1, 2, . . . , K, where T denotes the
length of the spectro-temporal signals. In accordance with the hyperspectral imaging
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terminology, we shall interchangeably refer to these end-member profiles as end-
member signatures. If we denote the multispectral time resolved fluorescence signal
recorded at a given pixel (say nth pixel) in a FLIM image by xn, then under the
linear mixing assumption, xn can be expressed as a linear combination of the K
end-member signatures, i.e.
xn = a1,n s1+a2,n s2+ · · ·+aK,n sK ⇔ xn = San, (5.1)
where S ≡ [s1, s2, · · · , sK ] ∈ RT×K and an ≡ [a1,n, a2,n, · · · , aK,n]T ∈ RK . Here,
the weights: a1,n, a2,n, . . . , aK,n represent the contributions or abundances of the K
end-members at the nth pixel. We we can then express the data matrix : X ≡
[x1,x2, · · · ,xN ] ∈ RT×N , containing the recorded spectro-temporal fluorescence de-
cays fromN pixels along its columns (henceforth referred to as data vectors) in matrix
notation as X = SA. We shall call S ≡ [s1, s2, · · · , sK ] ,the mixing matrix, which
holds the K end-member signatures in its columns; and A ∈ RK×N shall be referred
to as the abundance matrix, which contains the contributions of K end-members
(along rows) for each of the N pixels (along columns). Taking into account that
matrices X,S and A contain non-negative elements (denoted by: X,S,A < 0), the
problem we attempt to address can be stated as follows: Given a non-negative data
matrix X and the number of fluorophores K contributing to the bulk fluorescence sig-
nal, find the mixture and the abundance matrices S,A < 0 such that the product SA
best approximates X; i.e. X ≈ SA. This problem is more generally known as non-
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negative matrix factorization and appears in several research areas under different
names, most notably, spectral unmixing or blind source separation in hyperspectral
image analysis and multivariate curve resolution in chemometrics [54,55].
5.2.4 Geometrical Interpretation, Preprocessing and NMF Algorithms
5.2.4.1 Geometrical Interpretation
The solution to the NMF problem stated in the previous section can be better
understood by resorting to a geometrical interpretation of NMF. For meaningful in-
terpretation, the rows of A are interpreted to represent the relative abundance of
different end-members, in which case, they are assumed to follow a full-additivity con-
straint, i.e.
∑K
k=1 ak,n = 1 for n = 1, 2, . . . , N (in the following section, we discuss how
a simple normalization procedure can be employed to ensure that the full-additivity
constraint is satisfied). Under the linear mixing, non-negativity, and full-additivity
constraints, it then follows that the set X ≡ {xn∈ RT : xn=San, 1Tan = 1, n = 1, 2, . . . , N}
represents a K−1 dimensional simplex and estimating S amounts to finding the ver-
tices of this simplex. This is shown in Fig. 5.1 and Fig. 5.2 for cases when K = 2
and K = 3, respectively.
5.2.4.2 Data Preprocessing
The full-additivity constraint mentioned earlier, is not always satisfied in many
practical situations. This may happen when either the imaged area is large or in
situations where it is desired to use data acquired from different imaging sessions. In
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Figure 5.1: Data normalization to satisfy the full-additivity constraint. All possible
non-negative linear combinations of s1 and s2 lie in the blue shaded unbounded area
contained within s1 and s2. xn represents one such data vector. Normalizing data
vectors to unit L1-norm length amounts to rescaling them such that the tip of the
rescaled data vectors lie on the portion of the unit L1 norm circle (shown in dotted
lines) contained between the normalized end-member signatures s˜1 and s˜2, i.e. on
the line S ′1S
′
2, which represents a 1-D simplex.
the former case, it is mainly the variations in physical and chemical conditions, while
in the the latter case, it is the differences in experimental conditions that results in
the violation of the full-additivity constraint. This effect is commonly referred to
as signature variability in hyperspectral imaging literature and is characterized by
what is called spectral shape invariance, which means that although the shapes of
the end-member signatures do not vary much across different pixels, their scaling
or amplitude vary significantly over the imaged area [56]. In such a case, instead
of being contained on a K − 1 dimensional simplex, the data lies within a region
of the positive orthant of a T dimensional space enclosed by a convex polygonal
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cone spanned by the K columns of S. This is shown in Fig. 5.1 and Fig. 5.2 for
the case when K = 2 and K = 3, respectively, where the data vectors lie within
the cone (shown as blue shaded region) spanned by the end-member signatures, as
opposed to lying on a line (K = 2) and a triangular plane (K = 3), respectively.
In cases like these, a normalization technique inspired from the dark point fixed
transform (DPFT) can be performed to ensure that the normalized data satisfies the
full-additivity constraint [57,58]. This normalization involves scaling the data vectors
xn to have unit length in the L1-norm sense, i.e. if x˜n denotes the normalized data
vector, then x˜n = xn/‖xn‖1, where ‖x‖1 for a vector x = (x1, x2, . . . , xn) is defined
as: ‖x‖1 := |x1|+ |x2|+ · · ·+ |xn|. The linear mixing model stated in Eq. (5.1) can
then be reformulated as:
x˜n =
xn
‖xn‖1
=
∑K
k=1 ak,nsk
‖xn‖1
=
K∑
k=1
(
ak,n
‖sk‖1
‖xn‖1
)
︸ ︷︷ ︸
a˜k,n
(
sk
‖sk‖1
)
︸ ︷︷ ︸
s˜k
=
K∑
k=1
a˜k,ns˜k, (5.2)
where, s˜k = sk/‖sk‖1 denotes the rescaled end-member signatures and a˜k,n denotes
the corresponding rescaled contributions. Observing that ‖xn‖1 =
∑K
k=1 ak,n‖sk‖1,
it follows immediately that
∑K
k=1 a˜k,n = 1. The meaning of the term “relative abun-
dance” can now be better understood if we reconsider the NMF problem: X = SA,
where it is assumed that the row entries of a given column of S sum to 1; an as-
sumption that follows from the preceding discussion on normalization. In this case,
the relative abundance of an end-member (say kth) at a given pixel (say nth) can
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be interpreted as the relative contribution of the end-member’s signature signal (kth
column of A) to the bulk signal measured at the nth pixel (nth column of X).
The aforementioned normalization technique can also be understood intuitively
by considering a simple case, where we have a mixture of 2 end-members (K = 2),
for which the end-member signatures s1 and s2 are represented as vectors OS1 and
OS2 in Fig. 5.1. In a 2-D space, the unit L1-norm circle (set of vectors of norm 1) is
a square, which is shown in dotted lines in Fig. 5.1. Now, under the non-negativity
and linear mixing assumptions, a data vector xn, denoted by OX lies inside the blue
shaded region spanned by OS1 and OS2. The effect of normalizing a vector to unit
length in L1-norm sense can be thought of as scaling the length of that vector so that
the tip of the vector falls on the unit L1-norm circle. Thus, the normalized vector
x˜n is simply a scaled version of the original vector xn and is denoted by OX
′. By
a similar reasoning, the normalized end-member signatures, s˜1 and s˜2 (denoted by
vectors OS ′1 and OS
′
2) also lie on the unit L1-norm circle, whence it follows that any
vector expressed as a non-negative linear combination of s1 and s2 (or lying in the
blue shaded region) upon normalization will fall on the line joining S ′1 and S
′
2, which
represents a 1-D simplex.
5.2.4.3 NMF Algorithms
A class of algorithms to perform NMF is based on the above mentioned geometri-
cal interpretation of linear mixing model. These algorithms can be broadly grouped
into two categories. The first category includes algorithms that are based on the
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Figure 5.2: Simplex structure of data satisfying the non-negativity and full-additivity
constraint. In the general case, all possible non-negative linear combinations of s1
s2 and s3 lie in the blue shaded unbounded volume enclosed by s1 s2 and s3. On
imposing the full-additivity constraint all possible non-negative linear combinations
of s1 s2 and s3 are constrained to lie on the triangle S1S2S3, which represents a 2-D
simplex.
assumption that the set containing the end-member signatures S ≡ {sk ∈ RT , k =
1, 2, . . . , K} is a subset of the set X ≡ {xn ∈ RT , n = 1, 2, . . . , N} containing the
data vectors. This means that there are at least K pixels denoted by n1, n2, . . . , nK
such that xni = si, for i = 1, 2, . . . , K. This assumption is commonly referred to
as the pure pixel assumption and it simply means that the vertices of the simplex
described by the set of points in X are contained in X. The problem of estimating
end-member signatures is then reduced to finding the data vectors that form the
vertices of the simplex. Some popular algorithms based on this assumption are Ver-
tex Component Analysis (VCA), Pixel Purity Index (PPI) and N-FINDR [59–61].
The second category of NMF algorithms deal with a more realistic and difficult sit-
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uation, where the end-members appear rarely as pure pixels or, in other words, the
observed pixels are mostly a mixture of end-members. In such a case, the data does
not span the entire simplex and not many observed pixels are found at the vertices
of the simplex. The basic idea behind these algorithms is that even in the absence
of pure pixels, it may be possible in many cases to deduce the simplex structure of
the data. This idea was described in [62], where the author introduced a Minimum
Volume Transform (MVT) to infer the simplex structure in the absence of pure pix-
els. Based on the idea of MVT, several unmixing algorithms have been proposed
in the literature [58, 63, 64]. In this research, we present the application of Simplex
Identification via Split Augmented Lagrangian (SISAL) [65] to find the vertices of a
minimum volume simplex that encloses the multispectral FLIM data subject to the
non-negativity and full-additivity constraints, as discussed next.
Let us assume that the T dimensional data vectors are represented in a K di-
mensional subspace. If we denote the lower dimensional analogues for matrices X
and S by X and S, then the volume of the K − 1 dimensional simplex embedded in
K dimensions is |det (S)|. Furthermore, if we define Q ≡ S−1, then the optimization
problem that SISAL attempts to address can be mathematically stated as:
arg max
Q
−log |det (Q)|
subject to: QX < 0, 1TKQX = 1TN .
(5.3)
In order to account for outliers and noise in the data, the full-additivity hard con-
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straint is replaced by a soft constraint, which results in the following modified opti-
mization problem:
arg max
Q
−log |det (Q)|+ λ‖QX‖h
subject to: 1TKQX = 1TN ,
(5.4)
where ‖Y‖h ≡
∑
ij max{−[Y ]}ij, 0} and λ > 0 is the regularization parameter.
The optimization problem stated in Eq. (5.4) can be solved using a set of sequential
quadratic programming problems as discussed in [65]. An efficient MATLAB imple-
mentation of SISAL algorithm is made publicly available by the authors of [65] on
their website.
5.2.5 Feature Extraction and Classification
5.2.5.1 Feature Extraction
A total of 58 arterial tissue samples were imaged over a 2 mm × 2 mm FOV by
the multispectral FLIM system described earlier, generating a database of 58 mul-
tispectral FLIM data cubes of size 60 × 60 × 768 (x × y × t;λ1, λ2, λ3). The 3-D
multispectral FLIM image cubes were then processed to obtain two sets of 2-D fea-
ture maps, namely, the standard FLIM features and the NMF FLIM features. The
process of obtaining the standard FLIM feature has been described in Section 2.3
(also see Fig. 2.4). The process of obtaining NMF FLIM features is outlined in
Fig. 5.3. To perform NMF on multispectral FLIM data, the first step was “unfold-
ing” the multispectral FLIM data cube, which involved reshaping the 3-D data cube
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Figure 5.3: Schematic showing the process of performing NMF on a multispectral
FLIM data cube. The 3-D spectro-temporal cube is unfolded and normalized to
obtain a 2-D data matrix X. The data matrix is then factorized to yield the mixing
matrix S and the relative abundance matrix A, columns of which are reshaped to
obtain end-member relative abundance maps. These abundance maps comprise the
NMF FLIM features.
(x× y× t;λ1, λ2, λ3) to form a 2-D data matrix (t;λ1, λ2, λ3× xy). The data matrix
thus obtained was then normalized by using the DPFT and subsequently factorized
using the SISAL algorithm to yield a mixing matrix that contains the end-member
signatures and an abundance matrix. As shown in Fig. 5.3, rows of the abundance
matrix were reshaped to yield relative abundance maps for the end-members. These
maps constitute the NMF FLIM features. The performance of the two sets of features
was evaluated in terms of their ability to characterize multispectral FLIM images by
training and testing a multinomial logistic regression classification model (described
in the next section) on a subset of 21 out of 58 multispectral FLIM datasets (ho-
mogeneous datasets). Furthermore, to obtain pixel level classification, each pixel
of a FLIM image was considered to be a data-point, yielding a labeled data set of
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21 × 60 × 60 data-points. The classification performance for the logistic regression
model obtained from each set of features was compared by estimating the 10 fold
cross-validation (CV) misclassification error.
5.2.5.2 Multinomial Logistic Regression
Supervised classification is the problem of deriving a set of rules from a set of
pre-classified data and using that rule to classify a new data-point. The set of pre-
classified data-points along with the class for each data-point is called the training set
T = {(z1,y1), (z2,y2), . . . , (zN ,yN)}, where zn is referred to as the feature vector for
the nth data point and yn = [ yn,1, yn,2, . . . , yn,C ] is a 1×C vector such that yn,c = 1
if the nth data point belongs to cth class, and 0 otherwise. Multinomial logistic
regression is a supervised classification method that models the posterior probability
of a data point belonging to one of the C possible classes as a linear function of
z [66,67]. By fixing one of the classes as the baseline class, the conditional log-odds
of other classes with respect to the baseline class have the form:
log
Pr(Class = c|Z = z)
Pr(Class = C|Z = z) = βc,0 + β
T
c z, c = 1, 2, . . . , C − 1, (5.5)
where the Cth class is assumed to be the baseline class. The special form of logistic
regression model ensures that the posterior probabilities sum to 1, i.e.
∑
c
Pr (Class = c|Z = z) = 1
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. The problem of fitting a logistic regression model amounts to solving the maximum
likelihood problem defined as:
`(β) =
N∑
n=1
C−1∑
c=1
yn,c log
exp(βc,0 + β
T
c zn)
1 +
∑
c exp(βc,0 + β
T
c zn)
, (5.6)
where, the maximum likelihood estimate for the model parameter
β ≡ (β1,0,β1, β2,0,β2, . . . , βC−1,0,βC−1)
is obtained through an iterative optimization procedure like Newton-Raphson method
[67, 68]. The model thus obtained is then used to predict the posterior probability
of a given data- point belonging to one of the C classes and consequently assigning
it to the class with the maximum probability.
5.3 Results
5.3.1 Validation on Simulated Data
The proposed method was first validated on simulated multispectral FLIM data,
to which effect 10,000 data vectors (N = 10, 000) representing artificial mixtures of
collagen, lipids and elastin (K = 3) were generated. Collagen, lipids and elastin are
the dominant endogenous fluorophores in arteries and are thus relevant to the present
study. The end-member profiles for collagen, lipids and elastin (T = 510) were sim-
ulated based on the expected intensity and lifetime values for these fluorophores
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Figure 5.4: True end-member profiles (dark shade) plotted over estimated profiles
(light shade) for the simulation study. The profiles are plotted on a semilog (y) axis
to highlight the differences between the two profiles that were indistinguishable on a
linear scale.
obtained from a time resolved fluorescence study [28]. These profiles constituted the
S matrix and are referred to as the “true end-member profiles”. To form the relative
abundance matrix A, values for relative abundances were obtained by sampling from
a uniform distribution and subsequent normalization to enforce full-additivity. To
ensure that the data does not contain any pure pixel, data vectors having relative
abundance greater than 0.7 for any end-member were discarded. Finally, an additive
white Gaussian noise was added to simulate a SNR of 15 dB. To quantify the per-
formance of the algorithm on simulated data, 5 realizations of the noisy data were
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Figure 5.5: Scatter plot showing good agreement between the estimated and true
relative abundances. Black dashed line represents the line of perfect fit (y = x).
generated and the weighted mean absolute percent error (WMAPE), defined as:
WMAPE =
N∑
n=1
∣∣∣∣xn − x˜nxn
∣∣∣∣ · xn
N∑
n=1
xn
× 100% (5.7)
was calculated for S and A for each realization. The WMAPE in estimating A and S
was found to be 15.81± 0.42 and 9.67± 0.81 (mean ± standard error), respectively,
indicating good agreement between the actual and estimated values. Figure 5.4
shows the true end-member profiles plotted along with the estimated profiles for a
representative realization of the noisy data. The profiles are plotted on a semilog
graph to highlight the differences between the two profiles that were not evident on a
linear scale. The plot indicates good agreement between the two profiles. Likewise, a
scatter plot shown in Fig. 5.5 also indicates good match between the estimated and
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Figure 5.6: Comparison of the true and estimated normalized intensities and life-
times for collagen, elastin, and lipids in the three emission channels. (a) Normalized
intensity and (b) lifetimes in the three channels for the true and estimated end-
member profiles. Results indicate good agreement between the spectro-temporal
characteristics of the two profiles.
true relative abundances. To further compare the estimated profiles with the true
profiles, the normalized intensity and lifetimes in the three channels estimated from
the profiles are plotted in Fig. 5.6 (a) and (b) respectively. These plots suggest a
good match between the spectro-temporal characteristics of the true and estimated
end-members. The large mismatch between collagen’s lifetime in the third channel
is possibly a consequence of low signal level in collagen’s spectro-temporal profile in
the third channel.
5.3.2 Validation on Experimental Data: Feature Extraction
The method was also validated on experimental multispectral FLIM data ob-
tained from fresh human postmortem atherosclerotic coronary plaques. Standard
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and NMF FLIM features were extracted from the multispectral FLIM database
through the procedure outlined in the methods section. The end-member profiles
obtained via NMF are shown in Fig. 5.8. The profile in red (solid line) has maxi-
mum emission intensity in the first channel followed by a relatively lower intensity
in the second channel and least intensity in the last channel. This intensity trend is
characteristic of collagen. Likewise, the green (dotted line) and black (dashed line)
profiles have relatively same intensity in the first two channels but a lower intensity
in the third channel, which is characteristic of both lipids and elastin as shown in
the steady state spectra in Fig. 5.10 (a) (also [28]). To identify the end-members, we
deconvolved the decay profile corresponding to the dominant emission band for each
end-member and estimated the average lifetime from the deconvolved decays. This is
shown in Fig. 5.10 (b), where the log-transformed deconvolved profiles, loge(I(t)) are
plotted against time, t. In the case of a mono-exponential decay, the log-transformed
plots would be expected to be straight lines. Deviation from a straight line indicates
complex nature of decay kinetics. To estimate average lifetime from these plots, a
straight line fit based on least squares estimation was obtained and the average life-
time was estimated by calculating -1/slope of the best fit line. Based on the intensity
trends and lifetime values, the three end-member profiles were identified as collagen
(red, τavg = 7.1 ns), lipids (green, τavg = 10.8 ns) and elastin (black, τavg = 2.6 ns).
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(a) (b) 
(c) (d) 
Figure 5.7: Results of the statistical analysis on the standard FLIM features. The
values of the normalized fluorescence intensity in the three spectral channels from
the HC, HL and LCL groups (a) resemble the fluorescence emission spectra from
collagen, LDL and elastin, respectively (b). Similarly, the values of the fluorescence
lifetime from the HC, HL and LCL groups (c) resemble the fluorescence lifetime from
collagen, LDL and elastin, respectively (d).
5.3.3 Standard FLIM Features
The ability of the six standard FLIM features (normalized intensity and lifetime
in the three channels) to distinguish between the three histopathological classes was
assessed via the following statistical analysis. A 15×15 pixel block in each FLIM
image was counted as a single data point to reduce the effect of non-normality. The
nonparametric MannWhitney U-test was performed between every pair of classes,
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wherein P < 0.01 was considered significant. Results of the statistical analysis are
summarized in Fig. 5.7 (a)&(c). The bar plots denote the median value and the
error bars denote the first and third quartiles. For comparison, the plots of wave-
length dependent normalized emission spectrum and average lifetimes from purified
collagen, elastin and (low density lipoproteins) LDL measured with a time-resolved
spectroscopy system are also shown in Figure 5.7 (b)&(d). The median values for
the normalized intensity and lifetime for the HC and HL samples resemble those
of collagen and LDL respectively (characteristic strong emission in Channel 1 for
collagen and long lifetime in Channel 3 for LDL). The horizontal brackets above the
bars indicate significant difference among pairs (P<0.01).
5.3.4 Comparison of Standard FLIM and NMF Features
The two sets of features corresponding to a representative HC, HL and LCL
plaque from the homogeneous datasets are shown in Fig. 5.9. In each sub-figure,
the top row (A)-(C) shows the normalized fluorescence intensity maps for the three
spectral channels. Likewise, the second row (D)-(F) shows the lifetime maps for the
three channels. The relative abundance maps of the three end-members, namely,
collagen, lipids and elastin, constitute the NMF FLIM features that are shown in the
third row (G)-(I). Representative histopathological sections for each plaque type are
also shown in the last row (J) of each sub-figure. For the HC plaque (Fig. 5.9 (a)),
the fluorescence intensity was stronger in channel 1 than in channels 2 and 3, and
the average lifetime varied between 5–6 ns, which resembles the fluorescence emission
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Figure 5.8: End-member signatures obtained from the artery multispectral FLIM
data. Based on the spectro-temporal characteristics, the end-members were identified
as collagen (red, solid line), lipids (green, dotted line) and elastin (black, dashed line).
characteristics of collagen. In the histopathological section, the light blue stain color
indicates the presence of collagen. The relative abundance maps in this case, showed
higher abundance of collagen (0.61± 0.04) as compared to that of lipids (0.25± 0.04)
and elastin (0.17± 0.02). For the HL plaque (Fig. 5.9 (b)), the fluorescence intensity,
compared to the HC plaque, was lower in channel 1, similar in channel 2 and higher
in channel 3. The averaged lifetime gradually increased from ∼5 ns in channel 1 to
∼8 ns in channel 3. In the histopathological section, the empty areas indicate the
presence of lipids. The relative abundance maps in this case, showed the highest
abundance of lipids (0.57± 0.09) along with some collagen (0.33± 0.09), but signifi-
cantly lower amount of elastin (0.10± 0.05). Lastly, for the LCL plaque (Fig. 5.9 (c)),
the fluorescence intensity had similar values in channels 1 and 2 as the HL plaque
(due to the similar emission intensity profiles for elastin and lipids, see Fig. 5.10 (a)).
However, unlike HL, the lifetime maps in the case of LCL plaque were similar in
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Figure 5.9: Standard FLIM features: normalized intensity and lifetime maps (A-C
& D-F resp.) and NMF FLIM features: relative abundance maps (G-I) for three
homogeneous samples, one from each (a) High Collagen, (b) High Lipids and (c)
Low Collagen/Lipids class. Also shown are the representative histology sections for
each class (J).
the three channels (between ∼3–4 ns). The relative abundance maps for LCL type
of plaque suggested presence of collagen (0.41± 0.02) and elastin (0.40± 0.02) but a
significantly lower amount of lipids (0.21± 0.03).
5.3.5 Classification Performance on Homogeneous Datasets
To compare the performance of the two sets of features (standard FLIM vs. NMF
features) in terms of their ability to discriminate between the three plaque types
(HC, HL, LCL), two multinomial logistic regression models, one from each feature
set, were trained and tested on the homogeneous datasets. In the case of standard
FLIM features, the decision boundaries are hypersurfaces in a five-dimensional fea-
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Figure 5.10: (a) Steady state spectra for collagen, lipids (LDL) and elastin obtained
from time-resolved measurements (b) log-transformed fluorescence decays for colla-
gen, lipids and elastin fitted to straight lines. The negative inverse slope is equal to
a fluorophore’s average lifetime. Deviation from a straight line indicates the non-
mono-exponential nature of the decay.
ture space and cannot be visualized. However, in the case of NMF features, the
decision boundaries are lines in a 2-D feature space as shown in Fig. 5.11. As can
be seen in Fig. 5.11, the classifier partitions the feature space into 3 regions corre-
sponding to the three classes. In order to quantify the classification performance of
the classifiers, we computed the confusion matrices via 10 fold stratified CV, which
are shown in Fig. 5.12. The overall classification accuracy for the standard FLIM
features and the NMF features was estimated to be 98.3% and 96.1%, respectively.
5.3.6 Validation on Heterogeneous Plaques
We also compared the performance of the two classifiers trained on the homo-
geneous datasets by testing them on datasets of plaques showing heterogeneous
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Figure 5.11: Feature space partition obtained by the multinomial logistic regres-
sion classifier. The multinomial logistic regression classifier for the NMF features
partitions the feature space into three regions corresponding to the three classes:
High Collagen (HC), High Lipids (HL) and Low Collagen/Lipids (LCL) seperated
by linear decision boundaries (white region).
histopathology. Three examples of such validation are shown in Fig. 5.13 (a)-(c).
The first two rows: (A)-(C) & (D)-(F) in each sub-figure show the normalized in-
tensity and lifetime maps, respectively. The abundance maps for collagen, lipids
and elastin are shown in the third row: (G)-(I). The classification maps for classi-
fier trained on standard FLIM and NMF features are shown in panel (J) and (L),
respectively. For both classification maps, the probability of each FLIM image pixel
belonging to HC or HL class is color coded in red and green, respectively. We also
display a matching histology section for each plaque in panel (K) of each sub-figure.
Fig. 5.13 (a) shows the feature and classification maps for a plaque with regions
of LCL (top) and HC (bottom). The matching histology section for this sample
confirmed that the LCL region was IT and the HC region was fibrotic PIT. A plaque
showing regions of HC, HL and LCL is shown in Fig. 5.13 (b); a histology section
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Figure 5.12: Confusion matrix for the standard FLIM features (left) and the NMF
FLIM features (right). The diagonal entries indicate the number of pixels that were
correctly classified, while the off-diagonal entries indicate the misclassified pixels.
corresponding to the middle of the plaque confirmed that the HC region was fibrotic
PIT, the HL region showed foam cell infiltration, and the LCL region was IT. Fi-
nally, a plaque showing regions of HL (top-left) and LCL (bottom-right) is shown in
Fig. 5.13 (c); a histology section corresponding to the middle of the plaque confirmed
that the HL region was PIT highly infiltrated by foam cells, and the LCL region was
IT.
5.4 Discussion
In this study, we presented an application of NMF to interpret multispectral
FLIM data. We also demonstrated the potential application of the proposed method
for multispectral FLIM based tissue characterization using the coronary atheroscle-
rotic plaques as a test model. In the following, we discuss the main advantages
and limitations of the proposed method over the standard methods of interpreting
multispectral FLIM images.
The conventional method of interpreting multispectral FLIM images is based on
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comparing the average spectral intensity and lifetime values of a sample with a set of
possible known fluorophores. This method is very subjective in most cases, especially
when there are more than one fluorescing species contributing to the bulk fluores-
cence signal. In contrast, the NMF features provide a more direct and intuitive way
of interpreting FLIM images, because fluorophore abundance maps can be directly
related to tissue biochemistry. The application of NMF to the multispectral FLIM
data from human coronary plaques clearly demonstrated this aspect of the proposed
method, where it was shown how the NMF approach was not just able to identify
the main endogenous tissue fluorophores (i.e. elastin, collagen and lipids), but was
also able to quantify their relative abundance maps, allowing for direct biochemical
characterization of the atherosclerotic plaques.
To provide quantitative interpretation of FLIM images based on the intensity and
lifetime values, the most commonly used method assumes that all the constituent
fluorophores in a sample have mono-exponential decay kinetics. The sample fluores-
cence decay is then expressed as a multi-exponential model, in which each exponential
component is associated to each constituent fluorophore. The sample fluorescence
decay at each pixel is thus fitted to the multi-exponential model, and the estimated
normalized pre-exponential weights are interpreted as the relative contribution of
each constituent fluorophore to the bulk fluorescence signal [17, 49]. While such an
interpretation of FLIM images can be more informative than the analysis based on
single average lifetime value, it is restricted in a way, because many fluorophores are
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known to exhibit non-monoexponential decays thereby violating the assumption of
a mono-exponential decay associated to each constituent fluorophore. This is even
more pertinent when analyzing endogenous multispectral FLIM data, because many
endogenous fluorophores show non-monoexponential decay dynamics [22]. This how-
ever, is not a problem with the NMF approach, because it does not make any as-
sumption about the functional form of the end-member profiles (i.e. decay dynamics
of the constituent fluorophores). This is evident from the log-transformed fluores-
cence decay profiles for collagen, lipids and elastin retrieved via NMF and shown in
Fig. 5.10 (b), where the deviation of these plots from straight lines (dashed lines)
indicate the complex nature of the decay dynamics.
Kremers et al. recently proposed a method capable of handling fluorophores
showing non-monoexponential decays; however, its application was limited to two
species [49], like many other earlier studies [48,51]. This is mainly because the SNR
requirement for fitting a multiexponential model with more than two lifetimes is
very demanding. Thus, these methods can handle experimental FLIM data where
only two molecules can be simultaneously monitored. Moreover, in most of these
studies only the fluorescence lifetime but not the spectral information is used in the
unmixing process [49, 52]; e.g. in the method proposed by Kremers et al., only one
emission band was considered. Schlachter et al. recently proposed a method capable
of handling multispectral FLIM data; however, its application was limited to mono-
exponential fluorescence decays and to two species [52]. The NMF approach, on the
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other hand, can handle multispectral FLIM data originating from more than two
constituent fluorophores that is measured across an arbitrary number of emission
spectral bands. This can facilitate the identification of the underlying constituent
fluorophores, since the end-member profiles obtained via NMF contain both spectral
and temporal information which makes it possible to identify them with adequate
confidence. This was clearly demonstrated in our analysis of the multispectral FLIM
data from the human atherosclerotic plaques, where the three fluorophores were
correctly identified as elastin, collagen and lipids, as expected based on the well
characterized histopathology of atherosclerosis [69]. In this case, the identification of
the constituent fluorophores was performed based on both the spectral and lifetime
values of the estimated end-member profiles at three different emission bands. This
is in contrast to the standard FLIM analysis method, where only one lifetime value
is available for making such an identification. In such a case, unless guided by strong
evidence derived from tissue biochemistry, the identification of the latent fluorophores
can at best be only hypothesized.
Another advantage of the NMF approach over the standard FLIM data analy-
sis methods is that the NMF features (abundance maps) can be obtained directly
from the spectro-temporal FLIM intensity data in a computationally efficient manner
without the need for time deconvolution. The time complexity of SISAL algorithm
is estimated to be of the order O(NK) in [65], wherein the authors have also com-
pared the time performance of SISAL against other NMF algorithms. Furthermore,
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once the end-member profiles have been derived from a pre-recorded dataset, the
abundance maps for a new sample can be obtained quickly by performing a simple
inversion. This is unlike in the case of standard FLIM features, where unless ex-
tremely short excitation light pulses are used, time-deconvolution of the instrument
response from the fluorescence decay data is required to obtain lifetime maps [22].
The deconvolution coupled with multi-exponential model fitting involve iterative
optimization, which is both computationally expensive and time consuming. This
advantage of the proposed method, however, necessitates that the data is recorded
by the same system, i.e. the instrument response for all the data is the same.
The above stated advantages of the NMF method however, come with the need
of having enough diversity in data such that the simplex formed by the data vectors
is filled adequately to enable the inference of the underlying simplex structure. It
is only in such a case, that NMF algorithms are able to estimate the end-member
profiles and the corresponding relative abundances with confidence.
An important aspect of the proposed technique is the estimation of the number of
components (end-members) present in the linear mixing model. Several methods for
determining the number of end-member are reported in the literature, ranging from
relatively simple techniques like principal component and independent component
analysis to more complicated techniques like virtual dimensionality [70], maximum
noise fraction [71] and noise adjusted principal components [72] and many more.
While these techniques have been applied with varying degrees of success in different
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applications, there is no single approach generally accepted to work in all cases.
In our case, the choice of three end-members (K = 3) was primarily based on the
biochemical understanding of the underlying tissue. However, in cases where there
is no prior knowledge about the possible number of end-members, any or more than
one of the above techniques can be used in conjugation with the interpretation of
the end-member signatures obtained by NMF to decide on an appropriate number
of end-members.
Finally, we also validated the performance of the new set of FLIM features in
terms of their ability to discriminate between three types of atherosclerotic plaques.
The classification maps and the confusion matrices presented in the results section,
suggested that the NMF features are comparable to the standard FLIM features
in terms of their discriminatory power to differentiate between the three plaque
types. With the added advantage of ease of interpretation, we believe that the NMF
features can facilitate the translation of multispectral FLIM from predominantly a
lab imaging modality to clinical setting.
5.5 Conclusions
To summarize, we presented the application of NMF to multispectral FLIM data
to derive a set of NMF features that provides an intuitive and an objective way of
characterizing latent tissue fluorophores and their abundances. The method pre-
sented in this study made no assumption about the functional form of decay kinetics
of the fluorophores under study and can be obtained directly from the recorded mul-
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tispectral FLIM intensity data thereby obviating the need for deconvolution. As
discussed earlier, several studies on the application of FLIM to tissue diagnosis use
the difference in lifetime values to distinguish normal tissue from a pathological tis-
sue; however, the scope of such studies has been severely restricted to those two
ends of the disease-progression spectrum. We believe that this is mainly due to the
absence of techniques that can objectively characterize the latent tissue fluorophores
and quantify the changes in their abundance during the pathogenesis of a disease.
The method proposed in this study is an attempt in this direction, which would
expand the scope of FLIM in clinical graded diagnosis by providing an easy and
objective way of interpreting multispectral FLIM data. More generally, the method
detailed in this study can also be helpful in advancing the field of molecular imaging
and may find broad applicability in basic, pre-clinical and clinical research.
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Figure 5.13: Results of the classification performance on the heterogeneous datasets.
Standard FLIM features: normalized intensity and lifetime maps (A-C & D-F resp.)
and NMF FLIM features: relative abundance maps (G-I) for three heterogeneous
samples with regions of: (a) HC and LCL (b) HC, HL and LCL, and (c) HL and
LCL. Also shown are the histology sections from the center of the sample (K) with
matching regions in the classification maps obtained from the NMF features (J) and
the standard FLIM features (L) shown in orange arrows. Pixels in the classification
maps are color coded as red for HC, green for HL and black for LCL
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6. COMBINED MORPHOLOGICAL AND BIOCHEMICAL
IMAGING OF ATHEROSCLEROSIS
6.1 Introduction
Invasive imaging of coronary atherosclerotic plaque is limited to the evaluation of
its morphological features, while not evaluating metabolic processes like inflamma-
tion, oxidative stress, and dyslipidemia, that lead to its development [73–77]. Early
and intermediate-stage atherosclerotic plaques have thin fibrous caps, lipid-laden
cores, and localized inflammation that are inadequately visualized by using OCT or
intravascular ultrasound (IVUS) [78]. Convincing evidence exists to indicate that the
underlying mechanisms in coronary plaque development, leading to acute thrombo-
sis are multifactorial, involve complex interactions between structural, compositional,
biomechanical, cellular, and molecular processes in the vessel wall [79, 80]. Unfortu-
nately, there is no current imaging modality (noninvasive or intravascular) that can
provide such a level of plaque characterization.
Of the commercially available intravascular imaging tools, OCT provides the
highest resolution images and can be used to define the superficial morphological
features of atherosclerotic plaques; however, it does not offer any information about
the biochemical make-up of plaques [81–83]. Conversely, endogenous fluorescence
imaging techniques like FLIM enables the quantification of plaques’ biochemical con-
tent and the identification of lipid-rich and collagen-rich plaques [69], but does not
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provide any information about their morphology. In this study, we report how quan-
titative biochemical classification based on standard multispectral FLIM features
(two-dimensional normalized intensity and lifetime maps for each spectral channel
described in Chapter 2.3) can be combined with qualitative morphological OCT im-
age analysis for a more comprehensive evaluation of atherosclerotic plaques.
The coronary artery tissue database described in Section 3.2.1 was used in this
study. The data was acquired using the multimodal FLIM-OCT imaging system
described in Section 3.1.
6.2 Methods
6.2.1 Histology
On the basis of the histopathologic evaluation, each section was classified as either
intimal thickening (IT), pathologic intimal thickening (PIT), collagen-rich PIT hav-
ing >50% of collagen content (CLG-PIT), PIT with superficial lipid accumulation
(LIP-PIT), fibroatheroma (FA) with a cap having >50% of collagen content (CLG-
FA), FA with a lipid-rich cap (LIP-FA), thin-cap fibroatheroma (TCFA), calcified
FA (CA), or CA with a collagen-rich cap (CLG-CA). In addition, the collagen-rich
plaques (CLG-PIT, CLG-FA, CLG-CA) were grouped in a highcollagen (HC) cate-
gory, the lipid-rich plaques (LIP-PIT, LIP-FA, TCFA) were grouped in a high-lipid
(HL) category, and the other plaques (IT, PIT, CA) were grouped in a lowcolla-
gen/lipid (LCL) category.
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6.2.2 FLIM Plaque Evaluation
Similar to the analysis presented in Section 5, the endogenous FLIM signal was
analyzed to classify the tissue based on its biochemical composition as (High Col-
lagen) HC, (High Lipids) HL or (Low Collagen/Lipids) LCL plaques. The plaque
autofluorescence was quantified in terms of the relative fluorescence intensity and
the average lifetime at each pixel of the multispectral FLIM image. For statisti-
cal classification, Fisher’s linear discriminant analysis [67] was applied with the six
multispectral FLIM parameters as the feature vector for each pixel. A biochemical
map was then generated after classifying each pixel of an image to 1 of the 3 groups
(HC, HL, or LCL). Finally, each complete plaque segment was classified based on its
estimated biochemical map as follows: if 10% or more of the pixels were classified as
HL, the segment was classified as HL; if less than 10% of the pixels were classified as
HL but at least 20% of the pixels were classified as HC, the segment was classified
as HC; if less than 10% of the pixels were classified as HL and less than 20% of the
pixels were classified as HC, the segment was classified as LCL.
6.2.3 OCT Plaque Evaluation
The OCT B-scans (cross-sectional images) were reviewed by an interventional
cardiologist with clinical experience in the use of intravascular imaging. Following
standard criteria for intravascular OCT reading [83], each plaque was classified as
IT (showing two or three well-defined layers), PIT (showing a homogeneous signal-
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Figure 6.1: Histopathologic classification criteria of the multimodal OCT-FLIM cross
sections. Based on standard OCT cross-section evaluation, each plaque was classi-
fied as: intimal thickening (IT), pathologic IT (PIT), fibroatheroma (FA), thin-cap
FA (TCFA) or calcified FA (CA-FA). Based on the FLIM biochemical plaque char-
acterization as high lipid (HL), high collagen (HC), or low collagen/lipid (LCL):
each plaque was further classified as IT, PIT, fibrotic PIT (FIB-PIT), foam-cell infil-
trated PIT (FC-PIT), fibrotic FA (FIB-FA), foam-cell infiltrated FA (FC-FA), TCFA
or CA-FA.
rich region), FA (showing a signal-poor region with diffuse borders corresponding
to a necrotic-core or a lipid-pool), or CA (showing a signal-poor region with sharp
borders). An FA was considered TCFA if the cap thickness was <100µm.
6.2.4 Plaque Classification Based on FLIM and OCT Evaluation
To perform plaque evaluation based on FLIM and OCT, the FLIM-derived bio-
chemical map were superimposed on the surface of the OCT volumetric image as
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shown in Fig. 6.2 for a representative sample. The resulting multimodal plaque
representations were evaluated, and each plaque was placed into 1 of the 9 classes
following the criteria as defined in Fig. 6.1. Plaques classified as LCL by FLIM were
further classified as IT, PIT or CA based on their OCT evaluation. Plaques classified
as HC by FLIM were further classified as CLG-PIT, CLG-FA or CLG-CA based on
their OCT evaluation. Plaques classified as HL by FLIM were further classified as
LIP-PIT, LIP-FA or TCFA based on their OCT evaluation. The classification re-
sults were compared with the histopathology evaluation and the overall classification
accuracy was computed.
6.3 Results
6.3.1 Histology
The histopathology evaluation of the 46 imaged coronary sections resulted in the
following plaque distribution: IT (n=11), PIT (n=2) and CA (n=4) also grouped
as LCL plaques (n=17); CLG-PIT (n=7), CLG-FA (n=3) and CLG-CA (n=4) also
grouped as HC plaques (n=14); LIP-PIT (n=11), LIP-FA (n=2) and TCFA (n=2)
also grouped as HL plaques (n=15). Representative histology sections for each plaque
type are shown in Fig. 6.3.
6.3.2 FLIM Based Plaque Evaluation
The FLIM derived biochemical maps of all the IT, PIT and CA segments showed
less than 5% of HC or HL pixels; thus, they all (17 out of 17) were correctly classified
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as LCL plaques. The FLIM derived biochemical maps of all the CLG-PIT, CLG-
FA and CLG-CA segments showed less than 5% of HL pixels but more than 20%
of HC pixels; thus, they all (14 out of 14) were correctly classified as HC plaques.
Finally, the FLIM derived biochemical maps of all the LIP-PIT, LIP-FA and TCFA
segments showed more than 20% of HL pixels; thus, they all (15 out of 15) were
correctly classified as HL plaques.
6.3.3 Plaque Classification Based on FLIM and OCT
It should be noted that while OCT can image up to ∼1 mm deep into the tis-
sue, the biochemical assessment offered by FLIM is limited to the most superficial
∼200µm. The biochemical map was color-coded as LCL (light blue), HC (yellow), or
HL (red). Rendering the data as 2-D cross-sectional images (Fig.6.3, first, third and
fifth rows) is convenient for direct comparison with the histopathology slides (Fig.6.3,
second, fourth and sixth rows). This set of paired multimodal and histopathologic
images accurately illustrates the evaluation criteria used for classification. Sample
multimodal and histopathologic images of IT, PIT and CA are shown in the top six
panels (Fig. 6.3, light blue box). They all showed a FLIM biochemical map cor-
responding to LCL content, reflecting the lack of superficial lipids and collagen as
confirmed by histopathology. In addition, the OCT scans showed well-defined layers
for the IT, a bright homogeneous single layer for the PIT, and a low-intensity region
with well-defined borders corresponding to a calcified necrotic-core (NC) for the CA.
All these morphological features were confirmed by histopathology.
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(a) (b)
Figure 6.2: Multimodal OCT-FLIM volumes of representative coronary plaques.
Sample volumetric OCT images with the FLIM derived biochemical maps projected
on the lumen surface. (a) CA: the calcified necrotic core (CA-NC) is seen clearly on
the OCT cross sections; the biochemical FLIM map shows that the left shoulder and
part of the fibrous cap are high-collagen (HC), while the left shoulder is mostly low
collagen/lipid (LCL). (b) IT to PIT transition: the initial OCT cross sections clearly
indicate the intimal (I) and medial (M) layers on the IT region, with the FLIM map
showing LCL content; as the plaque transitions from IT to PIT, the OCT shows
a thickening of the intima, while the FLIM map indicates a transition from HC to
high-lipid (HL).
Sample multimodal and histopathologic images of CLG-FA, CLG-PIT and CLG-
CA are shown in the middle six panels (Fig. 6.3, yellow box). They all showed a
FLIM biochemical map corresponding to HC content, reflecting dominant superficial
collagen content as confirmed by histopathology. The OCT scan of the CLG-FA
showed a low-intensity region with diffuse borders covered by a thick bright layer
(>100µm), corresponding to a NC covered by a thick cap. The other OCT scans
showed a bright homogeneous single layer for the CLG-PIT, and a low-intensity
region with well-defined borders for the CLG-CA. All these morphological features
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were also confirmed by histopathology.
Sample multimodal and histopathologic images of LIP-FA, LIP-PIT and TCFA
are shown in the bottom six panels (Fig. 6.3, red box). They all showed a FLIM
biochemical map corresponding to HL content, reflecting dominant superficial lipid
content as confirmed by histopathology. The OCT scan of the LIP-FA showed a
low-intensity region with diffuse borders covered by a thick bright layer (>100µm),
corresponding to a NC covered by a thick cap. The OCT scan of the TCFA also
showed a low-intensity region with diffuse borders but in this case covered by a thin
bright layer (∼100µm), corresponding to a NC covered by a thin cap. The OCT scan
of the CLG-PIT showed a bright homogeneous single layer. All these morphological
features were also confirmed by histopathology.
Multimodal images from each of the 46 imaged coronary segments were evaluated
using the classification criteria described above (Fig.6.1). These results are summa-
rized in Table 6.1. All the LCL plaques correctly classified by FLIM were further
correctly identified as IT, PIT or CA based on their OCT evaluation. From all the
14 HC plaques correctly identified by FLIM, 12 were further correctly identified as
CLG-PIT, CLG-FA or CLG-CA based on their OCT evaluation; however, one CLG-
PIT was misclassified as CLG-FA, and one CLG-FA was misclassified as CLG-PIT.
From all the 15 HL plaques correctly identified by FLIM, 14 were further correctly
identified as LIP-PIT, LIP-FA or TCFA based on their OCT evaluation; however,
one LIP-PIT was misclassified as LIP-FA. Overall, 93.5% of the plaques (43/46) were
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Table 6.1: FLIM-OCT classification results
FLIM OCT
Classification Classification
IT PIT CA
LCL IT (n = 11) 11
17/17 PIT (n = 2) 2
CA (n = 4) 4
CLG-PIT CLG-FA CLG-CA
HC CLG-PIT (n = 7) 6 1
14/14 CLG-FA (n = 3) 1 2
CLG-CA (n = 4) 4
LIP-PIT LIP-FA TCFA
HL LIP-PIT (n = 11) 10 1
15/15 LIP-FA (n = 2) 2
TCFA (n = 2) 2
correctly identified using the combined OCT-FLIM evaluation.
6.4 Discussion
The results of this study suggest that simultaneous coregistered OCT and FLIM
imaging of coronary plaques enables the detailed characterization of the plaques
morphologic and lipid/collagen content, which can be used to assign each plaque
to its histopathologic class. Specifically, OCT is well suited to identifying layers,
fibrous cap thickness, necrotic cores, and calcification, while endogenous FLIM allows
identifying collagen- and lipid-rich plaques. Together, they enable the generation
of detailed maps of plaque morphology and biochemistry, which can then be used
to place the plaques in their respective histopathologic classes and to quantify the
heterogeneity within the classes.
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Recently, a consensus has been reached on standard criteria to identify fibrous
plaques, calcification, and necrotic/lipid pools in intravascular OCT cross-sectional
images (B-scans) [84]. In the present study, we have successfully applied these criteria
to correctly identify all of the IT, CA, and TCFA plaques. However, the discrimi-
nation between pathological intimal thickening and fibroatheroma was less effective,
highlighting the difficulty in identifying necrotic-cores or lipid-pools by OCT evalua-
tion, particularly when they are not superficial. This limitation has also been noted
by others [85]. In the present study, this is further confounded by the fact that our
OCT system is based at a center wavelength of 830 nm rather than the more typical
center wavelength of 1300 nm; hence, we expect poorer depth penetration for our
system.
The characterization of the lipid and collagen content of plaque is important for
histopathologic classification and for estimating a plaques propensity for develop-
ing into high-risk vulnerable plaque. In the present study, endogenous FLIM alone
was able to identify low-collagen/low-lipid plaques (including IT, PIT, and CA),
high-collagen plaques (including CLG-PIT, CLG-FA and CLG-CA), and high-lipid
plaques (including LIP-PIT, LIP-FA, and TCFA) with 100% sensitivity and 100%
specificity.
Although FLIM enables biochemical characterization of coronary plaques, little
information about plaque morphology can be inferred from the autofluorescence sig-
nal. For instance, LIP-PIT, LIP-FA and TCFA were all classified as HL based on
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FLIM regardless of their very different morphological characteristics. In contrast,
OCT enables morphologic characterization of coronary plaques but does not provide
specific information about plaque biochemistry. For instance, PIT, GLG-PIT and
LIP-PIT all appeared as bright and homogeneous single layers in their OCT scans
regardless of their different biochemical composition. Only when the FLIM plaque
classification was merged with the OCT B-scans (Fig.6.2 and 6.3) it was possible
to characterize plaque composition and morphology simultaneously. In particular,
the fibrous plaques correctly identified by OCT were further characterized as having
significant collagen or lipid content based on the FLIM classification (Fig. 6.3; PIT,
CLG-PIT, and LIP-PIT panels). Likewise, the fibroatheromas correctly identified
by OCT were further identified as having a fibrous cap and shoulders rich in colla-
gen or lipids (Fig. 6.3; CLG-FA and LIP-FA panels). Our results demonstrate that
simultaneous OCT and endogenous FLIM imaging of coronary plaque enables the
identification of all histopathologic types with high accuracy (>90%).
6.5 Conclusion
In conclusion, we have demonstrated the feasibility of simultaneous FLIM-based
biochemical and OCT-based morphologic characterization of coronary plaque at
practical spatial resolution and acquisition speeds, and the identification of all histopatho-
logic types of coronary atherosclerotic plaque using the proposed multimodal optical
imaging technology.
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Figure 6.3: Multimodal OCT-FLIM Cross Sections of Representative Coronary
Plaques. Rows 1 and 3: 2D multimodal images (cross sections) of representative
plaques from each histopathologic class. Rows 2 and 4: Corresponding histology
slides. Collagen appears blue, elastin is the black/dark lines, smooth muscle cells
appear as elongated red cells, lipids appear as empty space, and foam cells appear
with large white cytoplasm. All scale bars are 200µm.
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7. COMBINED MORPHOLOGICAL AND BIOCHEMICAL
IMAGING OF ORAL CANCER
7.1 Introduction
Despite the ease of accessibility of the oral cavity and identifiable risk factors, the
overall five year survival rate for oral cancer has not improved significantly over the
past several decades [14], mostly due to diagnosis at later stages. Late diagnosis of
oral cancer can be mainly attributed to the current method of detection and diagnosis
of oral malignancies, which relies on visual inspection followed by biopsy of suspicious
lesions. Biopsy being an invasive procedure is reserved for highly suspicious lesions,
which often leads to missing potentially malignant lesions. This is because many
malignant lesions on visual examination resemble benign lesions found in commonly
occurring less serious conditions of the oral cavity. Even in cases where suspicious
lesions are well identified, due to the complex nature of oral lesions, the choice of
the optimal site for biopsy remains an important concern. Additionally, high rates
of inter and intra-observer variability in histopathological evaluation of oral biopsies
further confound the diagnosis of oral cancer. To enable early detection of oral
cancer, there is, therefore, a need for a diagnostic tool that is noninvasive, reliable
and capable of being used in an out-patient setting. Such a tool should enable
screening for possible malignancy of large number of oral lesions, which are routinely
encountered by dentists and other physicians during visual examination of the oral
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cavity.
Progression of oral cancer is accompanied by alterations in the intrinsic fluores-
cence properties of the oral tissue as a consequence of changes in the relative abun-
dance of tissue autofluorophores like collagen, NADH and FAD [17, 39, 86]. These
changes result from processes like increased cellular invasion and NADH-FAD activ-
ity in the epithelial layer and degradation of stromal collagen, which are linked to oral
dysplasia. The ability of fluorescence imaging modalities to probe these biochemical
changes makes these them suitable for the diagnosis of oral cancer. As discussed in
Section 2.2, depending on the source of contrast, fluorescence imaging can be clas-
sified into two categories, namely, steady-state and time-resolved. There are two
main advantages of time-resolved measurements over steady-state measurements.
First, using fluorescence lifetime information from time-resolved measurements, it
is possible to distinguish between multiple fluorophores that have overlapping emis-
sion spectra and are thus indistinguishable using only intensity information available
from steady-state measurements. Second, unlike steady-state measurements, lifetime
measurements are more robust to variations in the intensity of excitation light and
fluorophores’ concentrations. Despite the aforementioned advantages of using life-
time information, most studies on the applications of fluorescence imaging for oral
cancer diagnosis are based on steady-state measurements. Lack of studies on the
diagnostic potential of lifetime based imaging methods can be partly explained by
the fact that unlike steady-state fluorescence measurements, which require simple
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instrumentation and minimal computation, instrumentation and signal processing
for lifetime based systems are more complex. Motivated by these observations, the
first part of the present study seeks to: (a) assess whether using lifetime information,
in addition to the fluorescence intensity information, offers any improvement in the
diagnostic potential of fluorescence based imaging for oral cancer, and (b) examine
the necessity of performing deconvolution (computational bottleneck in FLIM signal
processing) for obtaining lifetime by evaluating the performance of an approximate
method of lifetime estimation that does not require deconvolution.
In addition to changes in the relative abundances of tissue autofluorophores, pro-
gression of oral cancer is also associated with several structural modifications of the
oral epithelium, like epithelial thickening, loss of the layered structure, and irreg-
ular epithelial stratification [18, 20, 21]. OCT is an interferometry based structural
imaging modality that is capable of providing images of sub-surface tissue struc-
tures in a non-invasive way. The high-resolution imaging capability of OCT makes
it an attractive imaging modality for the diagnosis of oral cancer. Several studies on
the application of OCT for the diagnosis of oral cancer are discussed in the litera-
ture [20, 21]. However, most of these studies are based on visual inspection of OCT
B-scans to identify structural features associated with the malignant transformation
of the oral tissue. Visual assessment of tissue morphology, as reported in these stud-
ies, has a limited scope for two main reasons. First, it is extremely time-consuming
and practically impossible to visually evaluate the large amount of data obtained
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from a high-speed OCT system. Second, certain properties of tissue texture, like
graininess and homogeneity are difficult to quantify by direct visualization. There-
fore, it is highly desirable to develop automated image processing methods that can
quantitatively characterize tissue morphology and texture in OCT images. Moti-
vated by these observations, the second part of the present study investigates the
feasibility of using automated algorithms for quantifying structural features in OCT
images that are associated with the malignant transformation of the oral epithelium.
Finally, the overarching objective of this study was to examine the premise that
using both biochemical and morphological information obtained from FLIM and
OCT, respectively, will increase the diagnostic accuracy for oral cancer, compared
to using only one type of information. The analysis presented in this study was per-
formed on FLIM and OCT images from the Hamster Cheek Pouch Tissue Database
described in Section 3.2.2. To evaluate the diagnostic accuracy, a quantitative ap-
proach was taken in which several metrics (or features) describing various attributes
of FLIM and OCT images were first obtained by using signal and image processing
techniques. These features were subsequently used to design a statistical learning
model to perform automated classification. The performance of the different sets of
features was compared based on several measures of classification performance like
accuracy, sensitivity and specificity.
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7.2 Methods
7.2.1 Histopathological Evaluation
As stated earlier, the hamster cheek pouch database described in Section 3.2.2
was used in this study. Biopsy samples from the imaged areas were processed fol-
lowing standard procedures for histopathology analysis. On an average, 10 sections
per tissue sample were obtained and each section was assessed by a board certified
pathologist to be one of the following five grades: (i) normal (G0), (ii) hyperplasia
and hyperkeratosis (G1), (iii) hyperplasia with dysplasia (G2), (iv) carcinoma in situ
(G3), and (v) squamous cell carcinoma (G4). For classification analysis, the following
criteria was used to group the tissue samples into three classes: (i) class 1 (benign;
27 samples): samples from the control group (15 samples) and samples for which
all histology sections were graded as G1 (12 samples), (ii) class 2 (pre-cancerous ; 11
samples): samples for which at least 50% sections were graded as G2 or G3 and none
of the sections were graded as G4, and (iii) class 3 (cancerous ; 15 samples): samples
for which all sections were graded as G4. Samples that could not be assigned to any
of the above mentioned classes were excluded from the analysis.
7.2.2 FLIM Features
For a systematic analysis of FLIM features, we grouped the FLIM features into
two groups, namely, the exact FLIM features and the approximate FLIM features,
each containing nine features. The normalized intensities and average lifetimes maps
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for the three emission bands, which are obtained by following the standard multi-
spectral FLIM data processing outlined in Section 2.3 constituted six of the nine
exact FLIM features. As described in Section 2.3, the average lifetimes (denoted
by τavg), were computed based on the mathematical definition of lifetime stated in
Eq. (2.4). Another way of quantifying the rate of fluorescence decay is to assume
that the fluorophore follows a first order decay dynamics, in which case, lifetime can
be estimated as the time at which the fluorescence intensity is reduced to 1/e of its
maximum value. The lifetime estimated in this way shall be referred to as the 1/e
lifetime (denoted by τ1/e). The average lifetime is different from 1/e lifetime in that
it takes into account the entire fluorescence decay to estimate the lifetime, unlike
1/e lifetime, which is based on only the initial part of the fluorescence decay. Also,
for a fluorophore that follows a first order decay kinetics, the two lifetimes, τavg and
τ1/e, are equal. The addition of three 1/e lifetimes (one for each emission channel)
to the set of six multispectral FLIM features resulted in a total of nine exact FLIM
features.
The second group of features, called the approximate FLIM features also com-
prised normalized intensities, average and 1/e lifetimes. However, unlike the exact
lifetime features, which are obtained from the deconvolved decay profiles, the ap-
proximate lifetime features were estimated directly from the undeconvolved recorded
decay profiles by using the falling part of the recorded decay as a surrogate for the
deconvolved decay profile, and subsequently estimating the lifetimes (both average
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Figure 7.1: Schematic illustrating the process of obtaining exact and approximate
lifetime features. The exact lifetimes are obtained from the deconvolved intrinsic
decay h(t) shown in blue, whereas the approximate lifetimes ate obtained from the
falling part of the recorded decay y(t), denoted by h˜(t), which is used as a substitute
for the the intrinsic decay.
and 1/e) in a manner similar to the exact lifetimes. The process of obtaining the
exact and approximate lifetimes is illustrated in Fig. 7.1.
As noted in Section 3.1.3, the 2-D FLIM feature maps contain 60 × 60 pixels
over a FOV of 2×2 mm2. For the analyses presented here, these feature maps were
spatially averaged (window size: 3×3 pixels) to produce FLIM feature maps of size
20×20 pixels. In the following discussion, unless stated otherwise, “FLIM features”
shall be assumed to refer to the “exact FLIM features”.
7.2.3 OCT Features
Different layers of normal oral tissue appear as bright and dark bands in an OCT
B-scan. Stratum corneum, the topmost kertainized layer of the oral tissue can be seen
as a bright layer at the air-tissue interface in the B-scan of a normal tissue shown
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in Fig. 7.3 (a). Just below this layer, a dark band corresponding to the stratified
squamous epithelium (EP) can be seen. The epithelium layer is followed by lamina
propria (LP), top portion of which appears as a bright band. In contrast, B-scan of
a malignant oral tissue shows the absence of the layered structure, as can be seen in
Fig. 7.3 (b), where the B-scan has brightest intensity at the surface that gradually
fades off with depth. This layered versus non-layered structure is also evident by
examining the A-lines in a B-scan. In the case of a layered tissue, an A-line has
multiple prominent peaks corresponding to the different layers, whereas for a non-
layered tissue, there is only one prominent peak corresponding to the tissue surface
as shown in Fig. 7.2. To quantify these characteristics of A-lines, we defined two
types of A-line features, which shall be referred to as the “peaks and valleys” and
“crossings” features.
To calculate these features, the tissue surface was first identified by performing a
simple foreground/background segmentation using k-means algorithm (k = 2). The
B-scans were then aligned with respect to the tissue surface and were subsequently
filtered by a three-step process. First, to reinforce the layered structure in B-scans,
the aligned B-scans were filtered in the lateral direction by using a moving average
kernel of size 60 A-lines. Next, the A-lines were smoothened, in the axial direc-
tion, by performing morphological closing (to flatten valleys) followed by opening
(to eliminate narrow peaks) by flat structuring elements of size 10 and 5 pixels, re-
spectively. Finally, any spurious peaks having a normalized magnitude lower than
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0.1 were suppressed by performing h-maxima transformation of the A-lines. Details
about opening and closing operations, and h-maxima transform can be found in any
standard textbook on morphological image processing, e.g. [87]. To calculate the
peaks and valleys features, local maxima (peaks) and minima (valleys) of the fil-
tered A-lines were detected and the following four peaks and valleys features were
computed: (i) Σpi, (ii) Σpi − Σvi, (iii) Σpi + Σvi, and (iv) Σ(pi − (vi + vi+1)/2),
where pi and vi denote the normalized intensity values of the ith. peak and valley,
respectively. To calculate the crossings features, a crossings vector of size 15 × 1
was defined for each A-line, such that the jth element of the crossings vector is equal
to the number of times the filtered A-line would intersect an imaginary line drawn
parallel to the x-axis (depth) and having a y coordinate (normalized intensity value)
of (20 − j)/20 (shown as red broken lines in Fig. 7.2). Intuitively, if an A-line has
just one prominent peak, then all the elements of the crossings vector would be two,
whereas, for an A-line that has multiple prominent peaks, several elements of the
crossings vector would be greater than two, as illustrated in Fig. 7.2. Four crossings
features defined as the (a) mean, (b) median, (c) mode, and (d) standard deviation
of the elements of the crossings vector were computed. Overall, eight (four peaks and
valleys, and four crossings features ) A-line derived features were obtained for each
A-line, resulting in eight 2-D feature maps of size 600×600 pixels for each sample.
Speckle pattern in an OCT image of a tissue sample is known to contain information
about the size and distribution of the sub-resolution tissue scatterers [88, 89]. Oral
114
C
ro
ss
in
gs
 V
ec
to
r 
Depth (pixels) 
N
o
rm
al
iz
ed
 In
te
n
si
ty
 (
a.
u
.)
 
N
o
rm
al
iz
ed
 In
te
n
si
ty
 (
a.
u
.)
 
Depth (pixels) 
𝑝1 
𝑝2 
𝑝3 
𝑣1 
𝑣2 
𝑣3 
𝑣4 
N
o
rm
al
iz
ed
 In
te
n
si
ty
 (
a.
u
.)
 
Depth (pixels) 
C
ro
ss
in
gs
 V
ec
to
r 
N
o
rm
al
iz
ed
 In
te
n
si
ty
 (
a.
u
.)
 
Depth (pixels) 
N
o
rm
al
iz
ed
 In
te
n
si
ty
 (
a.
u
.)
 
Depth (pixels) 
𝑣1 𝑣2 
𝑝1 
N
o
rm
al
iz
ed
 In
te
n
si
ty
 (
a.
u
.)
 
Depth (pixels) 
Raw A-line Raw A-line 
Peak/Valley Analysis Peak/Valley Analysis 
Crossings Analysis Crossings Analysis 
Figure 7.2: Schematic illustrating the process of obtaining peaks & valleys and cross-
ings features from representative A-lines of a normal tissue (left column) and a ma-
lignant tissue (right column). Raw A-lines were first filtered to remove noise. Four
peaks & valleys features were computed as: (i) Σpi, (ii) Σpi − Σvi, (iii) Σpi + Σvi,
and (iv) Σ(pi− (vi + vi+1)/2), where pi and vi denote the normalized intensity values
of the peaks and valleys respectively. To compute the crossings features for an A-
line, the intensity axis was partitioned into 20 equal intervals (shown as red broken
partition lines). A 15×1 crossings vector was defined such that the jth. element is
equal to the number of times the filtered A-line intersects the jth. partition line. The
mean, median, mode, and standard deviation of the elements of the crossings vector
comprised the crossings features.
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a b 
Figure 7.3: Textural differences between B-scans of a normal and a malignant tissue
((a) & (b) respectively). The top surface and the epithelium boundary are shown in
blue and cyan respectively. Magnified views of portions of the delineated epithelial
regions (insets) show continuous dark and bright bands in the case of a normal tissue
and an interspersed speckled region for the malignant tissue.
dysplasia is often characterized by basal cell hyperplasia and epithelial proliferation.
The presence of dysplastic cells in the epithelium results in an interspersed speckle
pattern in an OCT B-scan, which is unlike the speckle pattern seen in B-scans of nor-
mal oral tissue, where different layers appear as more homogeneous bright and dark
regions (see insets in Fig. 7.3 (b)). To quantify this difference in speckle patterns,
several B-scan derived texture features were computed. The first step in computing
these features was to locate the boundary between the EP and LP. In the case of
a layered tissue, this was achieved by identifying the second prominent peak along
A-lines in an OCT B-scan, as shown in cyan in Fig. 7.3 (a). For cases where the
layered structure was absent, the B-scan was segmented into three regions using k-
means clustering algorithm, and the lower boundary of the topmost tissue region
was used as a proxy for the EP/LP boundary as shown in cyan in Fig. 7.3 (b). After
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delineating the EP/LP boundary, the region between the tissue surface (shown in
blue in Fig. 7.3) and the EP/LP boundary was selected for texture analysis based
on gray level run length (GLRL) analysis. A “gray level run” is a sequence of con-
secutive pixels, along some direction, having the same gray level value. The length
of a gray level run is the number of pixels in that run. To quantify texture based on
GLRL, a 2-D GLRL matrix for a given direction is computed. The element (i, j) of
the GLRL matrix denotes the number of times a run of length j and pixel value i
is found in the image. The process of obtaining a GLRL matrix for a 4×4 image is
illustrated in Fig. 7.4. To obtain texture features from a GLRL matrix, 11 different
measures characterizing different textural properties, like coarseness, non-uniformity,
etc. were computed (Fig. 7.4; also see [90]). To take care of the possible slanted tissue
orientation, the B-scans were aligned with respect to the air/tissue interface before
computing the texture features. The GLRL features were computed for both ver-
tical and horizontal directions, and for two quantization levels, namely, binary and
32 bits, yielding 44 B-scan derived texture features. The GLRL texture features for
each B-scan were computed over a sliding window region of size 60 A-lines within the
delineated epithelial region, resulting in B-scan derived texture feature maps of size
600×600 pixels. Both the A-line and B-scan derived OCT features were spatially
averaged (window size: 30×30 pixels) to yield a total of 52 2-D OCT feature maps
of size 20×20 pixels.
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Figure 7.4: Schematic illustrating the process of building a gray level run length
(GLRL) matrix. For a given direction (here 0◦), the element (i, j) of the GLRL
matrix denotes the number of times a run of length j and pixel value i is found in
the image. Runs of length one, two, and three in the example image are color coded
in purple, orange, and green respectively. Formulae to compute the eleven GLRL
derived texture features are also listed.
7.2.4 Classifier Design and Evaluation
The objective of a classification algorithm is to assign a category or class to a new
data-point belongs to based on the information obtained from an available set of pre-
classified data-points called the training set. A data-point is characterized by certain
attributes or features, and the problem of classifier design is that of estimating the
parameters of a model describing the functional relationship between the features
and class labels. The process of estimating these parameters constitutes the training
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phase of a classifier design. To evaluate the classification accuracy of a classifier, the
trained classifier is tested to predict the class of data-points in a test set, which have
preferably not been used for training (i.e. not included in the training set). The
predicted class labels produced by the classifier are compared with the true class
labels of the test data (assumed to be known) to evaluate the classification accuracy
of the classifier.
To evaluate the discriminatory potential of a set of features, a popular ensemble
classification algorithm called random forest was used in this study. Ensemble based
classification methods offer an attractive alternative to the traditional classification
algorithms to deal with complex classification problems. An ensemble based method,
in simple terms, combines several “weak classifiers” to produce a “strong classifier”.
This often results in an improved classification accuracy, which comes at the expense
of a higher computational overhead. The advantages of an ensemble based method
over a single classifier has been discussed in [91]. In this study, we used random
forest, which is an ensemble of simple decision trees classifiers [92].
In the context of classification algorithms, a data-point characterized by n fea-
tures is represented as a vector in a n-dimensional feature space. The process of
classification for a m-class problem can then be thought of as partitioning the fea-
ture space into m different regions. A decision tree classifier partitions the feature
space into disjoint rectangular regions based on a set of recursive binary rules. This is
illustrated in Fig. 7.5 (b) for the case of a three-class problem in a 2-D feature space.
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The rules in the case of the example shown in Fig. 7.5 (b) are: (i) Region 1 (green):
Feature 1 > 25, (ii) Region 2 (red): (Feature 1 < 25), and (Feature 2 < 20), and (iii)
Region 3 (blue): (Feature 1 < 25) and (Feature 2 > 20). These rules are graphically
represented as a tree shown in Fig. 7.5 (a), where each split point or an internal node
represents a binary question based on one of the features and the terminal nodes
of the tree represent a class label. The process of training a decision tree involves
determining the set of rules or the binary test conditions for each internal node of
the decision tree. Classifying a test data-point is straightforward once the decision
tree has been built. Starting from the top-most node, the data-point is propagated
down the tree based on the decision taken at each internal node, until it reaches a
terminal node. The class label associated with the terminal node is then assigned
to the test data-point. While decision trees have several advantages like the ability
to handle multiclass problems, robustness to outliers and computational efficiency,
they suffer from disadvantages like low prediction accuracy for complex classification
problems and high variance. Random forest overcomes the disadvantages of decision
trees by forming an ensemble of several decision trees (denoted by ntree, here) during
its training phase [93]. Assuming that the training set consists of N data-points
characterized by M features, each decision tree in a random forest is trained over a
set of M data-points obtained by sampling by replacement from the pool of training
data-points and f features chosen randomly from the M original features. In this
study, we used ntree = 200 and f =
√
M for training the random forest. To classify
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Figure 7.5: Random forest based classification. (a) Graphical representation of the
decision process in form of a binary tree (b) Partitioning of the feature space based
on the rules of the decision tree in (a) (c) The process of training and testing of a
random forest.
a new data sample, the class of the data sample is first predicted by each decision
tree and the final class predicted by the random forest is obtained by simply taking a
majority vote of the classes predicted by individual trees. This process is illustrated
in Fig. 7.5 (c).
To obtain an unbiased estimate of the classification accuracy, it is necessary to
test the performance of the classifier on an independent test data that has not been
used for training. Cross-validation is a commonly used, powerful resampling statis-
tical technique for estimating the generalization performance (i.e. the performance
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on data that has not been used for training) of an algorithm. In the context of
classification, cross-validation provides a means of obtaining an unbiased estimate
for the classification accuracy. In this study, a variant of the leave-one-out cross-
validation (LOO CV) method was used to estimate the classification accuracy. In
the standard LOO CV procedure, all but one data-points are used for training the
classifier and the left out data-point is used for testing. The process of training and
testing is repeated in an iterative round-robin fashion (each iteration called a fold of
CV), until all the data-points are used as test data-points. Since the data-points in
our study correspond to pixels in 2-D feature maps, to avoid optimistically biased
accuracy estimates resulting from spatial correlation between pixels, we performed
leave-one-sample-out cross-validation (LOSO CV), wherein CV folds were performed
over the datasets and not pixels. In addition to the mean classification accuracy (ob-
tained by averaging the accuracies obtained on individual CV folds), the classifier
performance was also evaluated by computing the sensitivity and specificity for each
class by pooling the results of the different CV folds.
7.2.5 Feature Selection for OCT Features
Feature selection is a process of selecting a subset of features from a large pool
of features. The objective of feature selection is to remove redundant (correlated)
and irrelevant features while retaining the most relevant features for building a pre-
dictive model. Getting rid of redundant and irrelevant features not just results in
reduced computational cost, both in terms of training and testing the model, but
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also provides a better understanding of the importance of different features in the
classification model. Due to the large number of correlated OCT features, we used
the Minimum Redundancy Maximum Relevance (mRMR) algorithm [94] to identify
the most important OCT features. mRMR is a mutual information based powerful
feature selection method that aims at selecting features that are mutually different
but highly relevant for classification. The predictive power of the smaller set of OCT
features obtained by mRMR algorithm was also evaluated by using a training and
testing procedure similar to what was used for the complete set of OCT features.
7.2.6 Statistical Comparison of Different Feature Sets
Two types of non-parametric statistical tests were used to compare the perfor-
mance of different feature sets. To compare the performance of two sets of features,
Wilcoxon signed rank test was used. The Wilcoxon test is a nonparametric proce-
dure for comparing two sets of paired observations. The classification accuracies for
different CV folds for classifiers based on the two feature sets were treated as the
different observations. The null hypothesis for the test was that there there was no
difference in the accuracies achieved by classifiers based on the two sets of features
and the two-sided alternative hypothesis stated that it was otherwise. The second
type of statistical test, namely, the Friedman test, was used to compare the per-
formance of more than two feature sets. The Friedman test is the non-parametric
equivalent of the ANOVA test. The null hypothesis for the Friedman test was that
there was no difference in the accuracies achieved by classifiers based on the dif-
123
ferent sets of features being compared, and the alternative hypothesis stated that
there was at least one pair of feature sets that had different classification accuracies.
Briefly, the Friedman test ranks the different features sets being compared for each
cross-validation fold based on the classification accuracies. The average ranks for the
different feature sets are then used to compute a test statistic (χ2F statistic) which is
compared against a critical value determined based on a pre-determined significance
level to check whether the measured average ranks are significantly different from
the mean rank. If the critical value is less than or equal to the test statistic, the
null hypothesis is rejected in favor of the alternative hypothesis. In such a case, a
post-hoc test is conducted to identify which features sets are different. In this study,
Holm procedure was used as a post-hoc test to compare the performance of the best
feature set (as judged by the mean ranks obtained during Friedman test) against the
remaining feature sets. Holm procedure compares a set of logically interrelated hy-
pothesis of comparisons between the control and other feature sets. For each pairwise
comparison, the p value is computed based on the mean rank difference between the
two groups and the null hypothesis that there is no difference between the two groups
is rejected if the p value is found to be less than an adjusted α value (called Holm
α in this study).The choice of the Holm procedure was motivated by the simplicity
and power of the test for performing multiple comparisons as described in [95].
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Table 7.1: Results of Wilcoxon signed rank test for comparing the classification
accuracies of the exact and approximate FLIM features (n = 48, α = 0.05)
Feature Sets Compared R+ R− T statistic z statistic p value
Exact FLIM - Approx. FLIM 156.5 371.5 156.5 -2.010 0.044
7.3 Results and Discussions
7.3.1 Comparison of the Exact and Approximate FLIM Features
The mean classification accuracy for the exact and approximate FLIM features
was found to be 83.7% and 80.7%, respectively. To test whether, in general, the ex-
act FLIM features performed better than the approximate features, Wilcoxon signed
rank test was performed. Out of the 48 pair-wise comparisons (corresponding to 48
LOSO cross-validation folds), the overall accuracy for the exact FLIM features was
found to be the same as that for the approximate FLIM features in 16 comparisons,
higher in 23 comparisons, and lower in the remaining 9 comparisons (refer Table A.1).
The results of the Wilcoxon signed rank test (n = 48, α = 0.05) summarized in Ta-
ble 7.1 indicated that the classification accuracies for the exact FLIM features were
statistically different (borderline p value = 0.044, α = 0.05) than those for the ap-
proximate features. Although the mean accuracy for the exact FLIM features was
found to be statistically higher than the approximate FLIM features, the borderline
p-value for the Wilcoxon test indicates that the difference between the overall ac-
curacies for the two sets of FLIM features was not substantive. This suggests that
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Table 7.2: Results of Friedman test for comparing the classification accuracies of
different FLIM feature sets (n = 48, df = 3, α = 0.05)
Feature Sets
All Int. Int. & τ1/e Int. & τavg
χ2F
statistic
p value
Mean Rank 3.4 1.6 2.2 2.8
58.02 <0.001
Mean Accuracy 0.836 0.638 0.690 0.784
an accuracy as high as that obtained by using the exact FLIM features can, in fact,
be obtained by using the approximate FLIM features. The advantage of using ap-
proximate features over the exact features being that estimating the approximate
FLIM features obviates the need for deconvolution and thus requires significantly
less computational effort.
7.3.2 Comparison of Intensity and Lifetime Features
To assess the improvement in the diagnostic accuracy achieved by using both
intensity and lifetime information, as opposed to only intensity, the classification
accuracies for the following four sets of exact FLIM features were compared: (i) All
FLIM features (3 normalized intensities, 6 lifetimes), (ii) Intensities only (3 features),
(iii) Intensities and 1/e lifetimes (6 features), and (iv) Intensities and average life-
times (6 features). As described earlier, for each cross-validation fold, all but one
datasets were used for training the classifier and the left-out dataset was used to
evaluate the classification accuracy. The classification accuracies for the different
sets of FLIM features evaluated over different cross-validation folds are listed in Ta-
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Table 7.3: Post-hoc comparison table for Friedman test for comparing different exact
FLIM features (n = 48, α = 0.05)
Hypothesis Feature Sets Mean Rank
z statistic p value
Holm
Index Compared Difference α
1 All - Intensity 1.81 6.88 <0.01 0.017
2 All - Intensity & τ1/e 1.22 4.62 <0.01 0.025
3 All - Intensity & τavg 0.64 2.41 0.016 0.05
ble A.2. To test for statistical differences between the four sets of FLIM features,
Friedman test (n = 48, α = 0.05) was performed. The results of the Friedman test
(χ2F = 58.02, df = 3, p < 0.001), summarized in Table 7.2, led to the rejection of the
null hypothesis, suggesting that significant difference exists between the classification
accuarcies of one or more feature sets. Based on the mean accuracies and ranks of the
different feature sets summarized in Table 7.2, it was hypothesized that classification
performance based on All FLIM features was better than the other feature sets. To
test this hypothesis, Holm post-hoc procedure was conducted in which the classifica-
tion accuracy of all FLIM features was compared with the other three feature sets.
The results of the Holm procedure are presented in Table 7.3. Based on the results of
the Holm procedure, all three hypotheses corresponding to the pairwise comparisons
between All FLIM features and the other three feature sets were rejected suggesting
that the performance of All FLIM features was statistically better that the other
three feature sets. These results are in agreement with the findings of an earlier
study investigating the potential of time-resolved fluorescence measurements for oral
127
cancer in a hamster cheek pouch model [96], where the authors found that using both
intensity and lifetime features as opposed to only intensity features resulted in a sig-
nificant improvement in the overall classification accuracy. The poor performance of
intensity based imaging systems in oral cancer screening has also been reported in
several other studies [97,98], where it has been noted that there is lack of substantive
evidence to suggest that the use of autofluorescence intensity based imaging system
improves the sensitivity and specificity of oral cancer beyond the conventional oral
examination.
Also, the fact that using both lifetimes τ1/e and τavg along with intensity results
in a statistically higher overall accuracy compared to using either of them with in-
tensity, suggests that using both lifetimes provide a more complete description of the
fluorescence decay dynamics. A similar result was reported in [96], where the authors
report highest overall classification accuracy for a combination of intensity, average
lifetime and zeroth order Laguerre coefficient features. Using both average lifetime
and zeroth order Laguerre coefficient in this case provides a better characterization
of the fluorescence decay, much like the combination of τ1/e and τavg in our study.
7.3.3 Comparison of FLIM and OCT Features
The mean accuracies and the ranks for the FLIM (9 features), OCT (52 fea-
tures), and FLIM & OCT (61 features) features are listed in Table 7.4 and a detailed
list of the classification accuracies for different cross-validation folds is presented
in Table A.4. To test for statistical differences between the three sets of features,
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Table 7.4: Results of Friedman test for comparing the classification accuracies of
FLIM and OCT features (n = 48, α = 0.05)
Feature Sets
FLIM & OCT FLIM OCT
χ2F
statistic
p value
Mean Rank 2.5 2.0 1.5
26.97 <0.001
Mean Accuracy 0.871 0.837 0.809
Friedman test (n = 48, α = 0.05) was performed. The results of the Friedman test
(χ2F = 58.02, df = 3, p < 0.001), summarized in Table 7.4, led to the rejection of the
null hypothesis, suggesting that significant difference exists between the classification
accuarcies of two or more feature sets. Based on the mean accuracies and ranks of the
different feature sets, it was hypothesized that combining FLIM and OCT features
leads to better classification accuracy than using either FLIM or OCT features. To
test this hypothesis, Holm test was performed to compare the classification accuracy
of the combined FLIM & OCT features with the individual OCT and FLIM features.
Based on the results of the Holm procedure presented in Table 7.5, the two hypothe-
ses corresponding to the pairwise comparisons between the combined FLIM & OCT
features and the individual OCT and FLIM features were rejected suggesting that
the classification accuracies for the combined FLIM & OCT features were in general,
better that the other the individual OCT or FLIM features.
In addition to the mean classification accuracies, the sensitivity and specificity
for each class (benign, pre-cancerous and cancerous) for the FLIM and OCT features
129
Table 7.5: Post-hoc comparison table for Friedman test for FLIM and OCT features
(n = 48, α = 0.05)
Hypothesis Feature Sets Mean Rank
z statistic p value
Holm
Index Compared Difference α
1 FLIM & OCT - OCT 0.948 4.64 <0.01 0.025
2 FLIM & OCT - FLIM 0.427 2.09 0.036 0.05
Table 7.6: Sensitivity and specificity for FLIM and OCT features
Sensitivity Specificity
Feature Sets Feature Sets
CLASS
FLIM
&
OCT
FLIM OCT
FLIM
&
OCT
FLIM OCT
Benign 0.883 0.876 0.784 0.909 0.918 0.878
Pre-cancerous 0.802 0.760 0.768 0.956 0.925 0.861
Cancerous 0.902 0.833 0.879 0.916 0.888 0.943
were also computed. Based on the sensitivity and specificity values listed in Table 7.6,
it can be said that the FLIM features had higher sensitivity and specificity than the
OCT features for the benign class. On the other hand, OCT features had better
sensitivity and specificity than the FLIM features for the cancerous class. For the
pre-cancerous class, the two sets of features performed comparably. By combining
both FLIM and OCT features, best sensitivity and specificity was achieved for all the
classes. The stacked bar graphs shown in Figure 7.6, provide further insights into
the classification performance. The graph shows the proportion of samples belonging
to a given class: benign, pre-cancerous, or cancerous that were classified correctly or
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(a) (b) 
(c) 
Figure 7.6: Stacked bar graph showing the proportion of samples belonging to a
given class: benign, pre-cancerous, or cancerous (x axis, true class) that were classi-
fied correctly (predicted as belonging to the same class) or incorrectly (predicted as
belonging to one of the other two classes) for (a) FLIM features (b) OCT features
(c) FLIM & OCT features.
incorrectly. The bar graph in Figure 7.6 (a) suggests that the classification based on
the FLIM features provides relatively poor discrimination between the pre-cancerous
and cancerous samples (cyan and red) compared to the classification based on the
OCT features. A possible reason for this could be that the information contained in
the fluorescence signal obtained from the samples in the pre-cancerous and cancerous
classes was not discriminatory enough to achieve an accurate class separation, a fact
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noted by several other researchers investigating the potential of fluorescence based
imaging methods for the diagnosis of oral cancer [96,99,100]. In contrast, significant
difference in tissue morphology between the pre-cancerous and cancerous classes
enables superior performance of the OCT features.
Likewise, the bar graph in Figure 7.6 (b) suggests that the OCT features per-
form poorly compared to the FLIM features in discriminating benign samples from
pre-cancerous samples (green and cyan). Following similar reasoning as before, this
confusion between the two classes could have possibly resulted from the lack of sen-
sitivity of the OCT features used in this study, to characterize differences in tissue
morphology between samples in the benign and pre-cancerous classes. To overcome
this limitation, more OCT features that are capable of characterizing morphologi-
cal indicators of early dysplasia like changes in keratinization, epithelial thickening,
irregular epithelial stratification and broadening of rete ridges could be evaluated
and combined with the existing set of OCT features. Although a standard crite-
ria of interpreting OCT B-scans for grading oral dysplasia has not been developed
yet, previous studies on OCT-based diagnosis of oral cancer, both in hamster cheek
pouches [18–20] and humans [21], have been successful in identifying the aforemen-
tioned histologically relevant morphological features in OCT B-scans, for diagnosing
oral pre-malignancies and malignancies.
The classification based on both FLIM and OCT features takes advantage of
the complimentary nature of the two feature sets to yield an improved performance
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compared to the classification based on either of those feature sets. This is indicated
by the highest sensitivity and specificity values for the combined FLIM and OCT
features, for all three classes.
It is of relevance to note that the performance of OCT-based classification is
mainly limited by the nature of OCT features in terms of their ability to provide a
sufficiently detailed description of tissue morphology. In this sense, one could expect
to achieve a superior classification performance by using a set of more descriptive
and richer OCT features. In the case of FLIM, however, a bigger limitation arises
from two other factors: (i) the difficulty to identify the specific sources contributing
to the bulk fluorescence measurements, and (ii) the complex and sometimes similar
nature of alterations in metabolic cofactors and structural proteins that occur in both
benign and malignant oral conditions. For example, loss of stromal fluorescence is
observed both in benign tissue with chronic inflammation caused by the breakdown
of collagen crosslinks and in dysplastic tissue due to epithelial thickening and degra-
dation of stromal collagen [18,101,102]. Similarly, an increase in keratin fluorescence
can be observed in both benign and malignant oral conditions, due to the presence
of keratotic lesions in both conditions [103, 104]. This was also noticed in the cur-
rent study, where histological evaluation of several samples in both the benign and
pre-cancerous classes revealed the presence of hyperkeratosis. Although an increase
in NADH fluorescence originating from the epithelial layer has been reported to be
strongly correlated with neoplastic progression [2, 16, 102], in the presence of kera-
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tinized epithelium, most of the excitation light is back-scattered, which significantly
reduces the fluorescence signal obtained from NADH. Morepver, the similarity in the
spectral and temporal fluorescence characteristics of collagen and keratin [105, 106]
further confounds the FLIM-based diagnosis of oral dysplasia.
Another possible reason for the relatively inferior performance of the different
feature sets for the pre-cancerous class could be the presence of mislabeled pixels
(data-points) in the training data that belong to the pre-cancerous class. As men-
tioned earlier, a sample was labeled pre-cancerous if the histological evaluation of
at least 50% of sections in that sample indicated some grade of dysplasia. This was
done due to the lack of samples belonging to the pre-cancerous class that had suffi-
ciently homogeneous evaluation across all the histology sections. As a result of this,
not all the pixels in a pre-cancerous sample (although all labeled as pre-cancerous)
were truly representative of pre-cancerous conditions. We speculate that the “label
noise” arising in this way could also be responsible for the confusion between the
pre-cancerous and other classes.
7.3.4 Selected OCT Features
To obtain a smaller set of most discriminatory OCT features from the original set
of OCT features, 52 sequential feature sets S1, S2, . . . , S52 (S1 ⊂ S2 ⊂ . . . S52) were
obtained using the mRMR incremental feature selection method. The sequential
feature sets are ordered such that the mth. feature set, Sm contains the m most
discriminatory features. The mean classification accuracies for the sequential feature
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Figure 7.7: Mean classification accuracies for the sequential OCT feature sets using
mRMR incremental feature selection procedure. The dashed black line line denotes
the mean accuracy obtained by using all 52 OCT features.
sets were subsequently computed by using a random forest based training and testing
procedure similar to what was used for the complete set of OCT features. Figure 7.7
shows the mean classification accuracies for the 52 sequential feature sets. The plot
suggests that using more than six features does not offer a significant improvement
in the mean classification accuracy; accuracy for the best six features being 0.804
compared to 0.809 for all OCT features. Specifically, the set of six most important
OCT features obtained by the mRMR algorithm included both A-line and B-scan
derived features, viz. : (i) std(crossings), (ii) LRLGE (90◦, 32 bits), (iii) RP (0◦, 2
bits), (iv) Σpi + Σvi, (v) RP (90
◦, 32 bits), and (vi) SRHGE (0◦, 2 bits).
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Figure 7.8: Results of the classification presented as diagnostic maps overlaid on
the OCT volumes for (a) benign (b) pre-cancerous and (c) cancerous samples. Also
shown are the representative histology sections taken from the samples. Scale bars
represent 200 µm
7.4 Conclusion
Very few studies have investigated the diagnostic potential of FLIM and OCT for
oral cancer. Even fewer studies have focused on algorithms for objective characteri-
zation of the biochemical and morphological changes associated with the progression
of oral cancer. In this study, we demonstrated, perhaps for the first time, the feasibil-
ity of using automated quantitative image analysis algorithms for extracting relevant
biochemical and morphological features from 3-D FLIM and OCT datasets, and us-
ing those features to perform automated diagnosis of oral cancer. The results of the
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classification algorithm could be presented in form of a diagnostic map overlaid on
the corresponding OCT volume for a better diagnostic interpretation as shown in
Fig. 7.8.
The main finding to emerge from the present study is that the synergy of bio-
chemical and morphological information obtained from FLIM and OCT, respectively,
increases the sensitivity and specificity for detecting malignant and pre-malignant le-
sions, compared to using features from only one type of modality. The second major
finding of our study is that using both intensity and lifetime FLIM features, as op-
posed to only intensity features, provides significant improvement in the diagnostic
accuracy. To circumvent the computational effort of deconvolution to obtain the
lifetimes, the performance of a new set of FLIM features, called the “approximate”
FLIM features was also analyzed. The results of this analysis indicated that a di-
agnostic power as high as that of the exact FLIM features can in fact be obtained
by using the approximate FLIM features. The advantage of using approximate fea-
tures over the exact features being that estimating the approximate features does
not require deconvolution and thus significantly reduces the computational effort.
The findings of this study are significant because they demonstrate the feasibility
of using automated algorithms for performing the diagnosis of pre-malignant and
malignant lesions based on FLIM and OCT data. We recognize that the sample
size used in this study was rather small, and were not truly representative of the
vast gamut of histological alterations that accompany the progression of oral can-
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cer. A further study using a larger pool of samples with more diverse histological
presentations is therefore warranted to fully substantiate the findings of the current
study.
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8. SUMMARY
With significant progress made in the design and instrumentation of optical imag-
ing systems, factors like acquisition speed and data transfer rate, which presented
early challenges in the development of various optical imaging techniques are no
longer a major concern. The high-speed imaging capability of these systems, however,
poses a new challenge of processing, interpreting and visualizing the vast amount of
information contained in the data collected in near real-time. The prohibitively large
amount of data obtained from these systems makes manual analysis by an expert
virtually impossible. In the absence of automated methods for data analysis, then,
the full potential of these optical imaging technologies remains largely underutilized.
This is an even bigger issue in the case of functional imaging modalities like FLIM,
where the indirect nature of the imaging signals makes the interpretation of images
(fluorescence intensity and lifetime maps in the case of FLIM) complex and less intu-
itive. The lack of tools for automated analysis for diagnostic applications, a problem
which remains largely unaddressed, formed the central theme of this dissertation.
An automated image analysis approach involves three major steps, namely, feature
extraction, classification, and visualization. In this dissertation, several computa-
tional methods for performing these different steps were described in the context of
two imaging modalities: OCT and FLIM. The results of this study demonstrated the
feasibility of using automated methods for extracting biochemical information from
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FLIM data and morphological information from OCT data and combining them for
a more comprehensive diagnosis of atherosclerosis and oral cancer.
Use of automated algorithms for clinical diagnosis, which form the basis of com-
puter aided diagnosis (CAD) [107, 108], has already started to make an impact in
conventional radiology. One of the most successful applications of CAD has been in
mammography based screening for breast cancer, where CAD based large prospective
studies like [109] have reported a gain of approximately 20% in the early detection
of malignant breast tumors in mammograms. The success of CAD in breast cancer
screening and diagnosis has led to commercialized CAD systems like ImageChecker R©
(Hologic, Inc.) and M-Vu CAD R© (VuCOMP, Plano, Texas) have been successful in
gaining approval from the U.S food and drug administration (FDA). It is reported
that more than 1500 CAD systems are currently in use in assisting radiologists in
the early detection of breast cancer at many hospitals, clinics and screening cen-
ters around the world [110]. Other areas in radiology where CAD systems are used
include detection of lung nodules in X-ray images (Philips xLNA Enterprise), and
diagnosis of advanced prostrate cancer based on bone scintigraphy (EXINI Diagnos-
tics, Sweden), to name a few. The initial success of CAD in radiological imaging has
encouraging implications for the use of automated methods in optical imaging.
Most optical imaging modalities, although showcased as promising diagnostic
tools in the academic world, remain far from being applicable in a clinical setting.
At this time, it is difficult to speculate the success of optical imaging in clinical
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diagnosis. However, there can be little doubt that automated data analysis will play
a pivotal role in the successful commercialization of any optical imaging modality
by enabling large scale quantitative cross-sectional studies in the validation phase
and eventually by enhancing the diagnostic power in the deployment phase. In this
sense, automated data analysis is one of the essential pillars on which the future of
optical imaging rests.
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APPENDIX A
TABLES FOR THE STATISTICAL TESTS DESCRIBED IN
SECTIONS 7.3.1–7.3.3
Table A.1: Comparison of classification accuracies for classifiers based on the exact
and approximate FLIM features. For each CV fold, all but one dataset were used
for training the classifier and the classification accuracy was estimated by testing the
classifier on the left-out dataset listed under the dataset column. The differences,
ranks and signs were used to perform a Wilcoxon signed rank test summarized in
Table 7.1 to compare the classification accuracies for the two sets of FLIM features
Accuracy
CV Exact Approx.
Fold Dataset FLIM FLIM Difference Rank Sign
1 JJN03-03 1.00 1.00 0.00 1 +
2 JJN03-04 0.78 1.00 0.22 23 -
3 JJN04-02 1.00 1.00 0.00 N/A
4 JJN05-01 1.00 1.00 0.00 N/A
5 JJN05-04 1.00 1.00 0.00 N/A
6 JJN05-05 1.00 1.00 0.00 N/A
7 JJN08-03 1.00 1.00 0.00 N/A
8 JJN12-04 1.00 1.00 0.00 N/A
9 JJN15-03 1.00 1.00 0.00 N/A
10 JJN16-03 1.00 1.00 0.00 N/A
11 JJN16-09 1.00 1.00 0.00 N/A
12 JJN17-05 1.00 1.00 0.00 N/A
13 JJN18-03 1.00 1.00 0.00 N/A
14 JJN19-03 1.00 1.00 0.00 N/A
15 JJN20-01 1.00 1.00 0.01 4 +
16 JJT02-01 1.00 0.84 0.16 21 +
17 JJT02-04 1.00 0.71 0.29 27 +
18 JJT03-02 0.02 0.64 0.62 30 -
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Table A.1 – Continued from previous page
Accuracy
CV Exact Approx.
Fold Dataset FLIM FLIM Difference Rank Sign
19 JJT07-03 0.96 0.40 0.56 29 +
20 JJT07-04 0.00 0.07 0.07 11 -
21 JJT09-01 0.83 0.21 0.62 31 +
22 JJT09-03 0.70 0.61 0.09 13 +
23 JJT10-02 0.99 0.96 0.03 10 +
24 JJT13-01 0.93 0.84 0.08 12 +
25 JJT12-02 0.98 0.99 0.00 1 -
26 JJT12-04 0.75 0.76 0.01 6 -
27 JJT17-05 0.11 0.00 0.11 16 +
28 JJT21-06 0.90 0.77 0.13 18 +
29 JJT24-04 0.96 0.95 0.01 7 +
30 JJT24-07 0.93 0.69 0.24 25 +
31 JJT24-09 0.98 0.87 0.12 17 +
32 JJT25-06 0.00 0.91 0.91 32 -
33 JJT27-04 0.99 0.75 0.25 26 +
34 JJT27-10 0.62 0.72 0.09 14 -
35 JJT28-11 0.51 0.74 0.23 24 -
36 JJT16-05 0.99 0.99 0.01 5 +
37 JJT16-10 0.97 0.94 0.03 9 +
38 JJT18-05 0.77 0.26 0.51 28 +
39 JJT18-06 1.00 1.00 0.00 N/A
40 JJT18-07 0.47 0.34 0.13 19 +
41 JJT23-04 0.74 0.59 0.15 20 +
42 JJT25-07 1.00 1.00 0.00 3 +
43 JJT26-06 1.00 1.00 0.00 N/A
44 JJT27-03 1.00 1.00 0.00 N/A
45 JJT28-06 0.73 0.83 0.10 15 -
46 JJT28-08 1.00 1.00 0.00 N/A
47 JJT28-12 0.61 0.45 0.16 22 +
48 JJT32-08 1.00 0.98 0.02 8 +
Mean Accuarcy 0.837 0.807
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Table A.2: Comparison of classification accuracies for classifiers based on different
FLIM features. For each CV fold, all but one dataset were used for training the
classifier and the classification accuracy was estimated by testing the classifier on
the left-out dataset listed under the dataset column
CV Accuracies for FLIM Features
Fold Dataset All Int. Int. & τ1/e Int. & τavg
1 JJN03-03 1.000 0.883 0.950 1.000
2 JJN03-04 0.780 0.603 0.483 0.995
3 JJN04-02 1.000 0.540 0.760 1.000
4 JJN05-01 1.000 0.853 0.965 1.000
5 JJN05-04 1.000 0.843 0.998 1.000
6 JJN05-05 1.000 0.510 0.635 1.000
7 JJN08-03 1.000 0.738 0.998 1.000
8 JJN12-04 1.000 0.839 0.814 1.000
9 JJN15-03 1.000 0.768 0.738 1.000
10 JJN16-03 1.000 0.998 0.998 1.000
11 JJN16-09 1.000 0.992 1.000 1.000
12 JJN17-05 1.000 0.705 0.693 1.000
13 JJN18-03 1.000 0.983 0.998 1.000
14 JJN19-03 1.000 0.873 1.000 1.000
15 JJN20-01 1.000 0.790 0.818 1.000
16 JJT02-01 1.000 0.816 0.572 1.000
17 JJT02-04 1.000 0.865 0.589 1.000
18 JJT03-02 0.018 0.388 0.003 0.015
19 JJT07-03 0.958 0.770 0.113 0.658
20 JJT07-04 0.000 0.285 0.583 0.000
21 JJT09-01 0.830 0.388 0.373 0.514
22 JJT09-03 0.698 0.360 0.193 0.848
23 JJT10-02 0.990 0.583 0.815 0.990
24 JJT13-01 0.925 0.358 0.863 0.845
25 JJT12-02 0.983 0.478 0.945 0.973
26 JJT12-04 0.746 0.075 0.061 0.587
27 JJT17-05 0.110 0.000 0.048 0.008
28 JJT21-06 0.898 0.430 0.705 0.768
29 JJT24-04 0.963 0.443 0.550 0.578
30 JJT24-07 0.930 0.304 0.368 0.635
31 JJT24-09 0.980 0.545 0.770 0.900
32 JJT25-06 0.000 0.213 0.528 0.000
Continued on next page
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CV Accuracies for FLIM Features
Fold Dataset All Int. Int. & τ1/e Int. & τavg
33 JJT27-04 0.993 0.473 0.843 0.833
34 JJT27-10 0.623 0.000 0.058 0.468
35 JJT28-11 0.509 0.576 0.501 0.574
36 JJT16-05 0.995 0.960 0.995 0.987
37 JJT16-10 0.968 0.949 0.978 0.863
38 JJT18-05 0.768 0.168 0.580 0.310
39 JJT18-06 1.000 0.991 1.000 1.000
40 JJT18-07 0.470 0.083 0.360 0.383
41 JJT23-04 0.735 0.588 0.675 0.648
42 JJT25-07 1.000 0.997 0.997 0.997
43 JJT26-06 0.998 1.000 1.000 0.995
44 JJT27-03 0.997 0.994 0.997 0.994
45 JJT28-06 0.734 0.688 0.741 0.703
46 JJT28-08 1.000 1.000 1.000 1.000
47 JJT28-12 0.609 0.497 0.525 0.639
48 JJT32-08 0.997 0.959 0.967 0.949
Mean Accuarcy 0.836 0.638 0.690 0.784
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Table A.3: Ranks for the data presented in Table A.2 for performing the Friedman
test to compare the classification accuracies for the different sets of FLIM features.
CV Ranks for FLIM Features
Fold Dataset All Int. Int. & τ1/e Int. & τavg
1 JJN03-03 3.5 1.0 2.0 3.5
2 JJN03-04 3.0 2.0 1.0 4.0
3 JJN04-02 3.5 1.0 2.0 3.5
4 JJN05-01 3.5 1.0 2.0 3.5
5 JJN05-04 3.5 1.0 2.0 3.5
6 JJN05-05 3.5 1.0 2.0 3.5
7 JJN08-03 3.5 1.0 2.0 3.5
8 JJN12-04 3.5 2.0 1.0 3.5
9 JJN15-03 3.5 2.0 1.0 3.5
10 JJN16-03 3.5 1.5 1.5 3.5
11 JJN16-09 3.0 1.0 3.0 3.0
12 JJN17-05 3.5 2.0 1.0 3.5
13 JJN18-03 3.5 1.0 2.0 3.5
14 JJN19-03 3.0 1.0 3.0 3.0
15 JJN20-01 3.5 1.0 2.0 3.5
16 JJT02-01 3.5 2.0 1.0 3.5
17 JJT02-04 3.5 2.0 1.0 3.5
18 JJT03-02 3.0 4.0 1.0 2.0
19 JJT07-03 4.0 3.0 1.0 2.0
20 JJT07-04 1.5 3.0 4.0 1.5
21 JJT09-01 4.0 2.0 1.0 3.0
22 JJT09-03 3.0 2.0 1.0 4.0
23 JJT10-02 3.5 1.0 2.0 3.5
24 JJT13-01 4.0 1.0 3.0 2.0
25 JJT12-02 4.0 1.0 2.0 3.0
26 JJT12-04 4.0 2.0 1.0 3.0
27 JJT17-05 4.0 1.0 3.0 2.0
28 JJT21-06 4.0 1.0 2.0 3.0
29 JJT24-04 4.0 1.0 2.0 3.0
30 JJT24-07 4.0 1.0 2.0 3.0
31 JJT24-09 4.0 1.0 2.0 3.0
32 JJT25-06 1.5 3.0 4.0 1.5
33 JJT27-04 4.0 1.0 3.0 2.0
34 JJT27-10 4.0 1.0 2.0 3.0
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CV Ranks for FLIM Features
Fold Dataset All Int. Int. & τ1/e Int. & τavg
35 JJT28-11 2.0 4.0 1.0 3.0
36 JJT16-05 3.5 1.0 3.5 2.0
37 JJT16-10 3.0 2.0 4.0 1.0
38 JJT18-05 4.0 1.0 3.0 2.0
39 JJT18-06 3.0 1.0 3.0 3.0
40 JJT18-07 4.0 1.0 2.0 3.0
41 JJT23-04 4.0 1.0 3.0 2.0
42 JJT25-07 4.0 2.0 2.0 2.0
43 JJT26-06 2.0 3.5 3.5 1.0
44 JJT27-03 3.5 1.5 3.5 1.5
45 JJT28-06 3.0 1.0 4.0 2.0
46 JJT28-08 2.5 2.5 2.5 2.5
47 JJT28-12 3.0 1.0 2.0 4.0
48 JJT32-08 4.0 2.0 3.0 1.0
Mean Rank 3.4 1.6 2.2 2.8
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Table A.4: Comparison of classification accuracies for classifiers based on different
features. For each CV fold, all but one dataset were used for training the classifier
and the classification accuracy was estimated by testing the classifier on the left-out
dataset listed under the dataset column
CV Accuracies for Different Features
Fold Dataset FLIM & OCT FLIM OCT
1 JJN03-03 1.000 1.000 0.995
2 JJN03-04 1.000 0.780 0.998
3 JJN04-02 1.000 1.000 1.000
4 JJN05-01 1.000 1.000 1.000
5 JJN05-04 1.000 1.000 0.998
6 JJN05-05 1.000 1.000 0.935
7 JJN08-03 1.000 1.000 1.000
8 JJN12-04 1.000 1.000 0.907
9 JJN15-03 1.000 1.000 0.398
10 JJN16-03 1.000 1.000 0.158
11 JJN16-09 1.000 1.000 0.510
12 JJN17-05 0.995 1.000 0.013
13 JJN18-03 1.000 1.000 1.000
14 JJN19-03 1.000 1.000 1.000
15 JJN20-01 1.000 1.000 0.858
16 JJT02-01 0.997 1.000 0.874
17 JJT02-04 1.000 1.000 0.964
18 JJT03-02 0.050 0.018 0.878
19 JJT07-03 1.000 0.958 1.000
20 JJT07-04 0.000 0.000 0.935
21 JJT09-01 0.481 0.830 0.135
22 JJT09-03 0.915 0.698 0.665
23 JJT10-02 0.998 0.990 0.900
24 JJT13-01 0.995 0.925 0.735
25 JJT12-02 0.980 0.983 0.535
26 JJT12-04 0.966 0.746 0.626
27 JJT17-05 0.390 0.110 0.958
28 JJT21-06 0.880 0.898 0.653
29 JJT24-04 0.563 0.963 0.388
30 JJT24-07 0.962 0.930 0.933
31 JJT24-09 0.958 0.980 0.920
32 JJT25-06 0.023 0.000 0.998
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CV Accuracies for Different Features
Fold Dataset FLIM & OCT FLIM OCT
33 JJT27-04 1.000 0.993 0.960
34 JJT27-10 0.953 0.623 0.625
35 JJT28-11 0.818 0.509 0.799
36 JJT16-05 0.997 0.995 0.989
37 JJT16-10 0.997 0.968 0.990
38 JJT18-05 0.825 0.768 0.868
39 JJT18-06 1.000 1.000 1.000
40 JJT18-07 0.705 0.470 0.695
41 JJT23-04 0.758 0.735 0.728
42 JJT25-07 1.000 1.000 0.990
43 JJT26-06 1.000 0.998 0.953
44 JJT27-03 0.997 0.997 0.980
45 JJT28-06 1.000 0.734 0.980
46 JJT28-08 1.000 1.000 0.968
47 JJT28-12 0.614 0.609 0.581
48 JJT32-08 0.995 0.997 0.882
Mean Accuarcy 0.871 0.837 0.809
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Table A.5: Ranks for the data presented in Table A.3 for performing the Friedman
test to compare the classification accuracies for the different sets of features.
CV Ranks for Different Features
Fold Dataset FLIM & OCT FLIM OCT
1 JJN03-03 2.5 2.5 1.0
2 JJN03-04 3.0 1.0 2.0
3 JJN04-02 2.0 2.0 2.0
4 JJN05-01 2.0 2.0 2.0
5 JJN05-04 2.5 2.5 1.0
6 JJN05-05 2.5 2.5 1.0
7 JJN08-03 2.0 2.0 2.0
8 JJN12-04 2.5 2.5 1.0
9 JJN15-03 2.5 2.5 1.0
10 JJN16-03 2.5 2.5 1.0
11 JJN16-09 2.5 2.5 1.0
12 JJN17-05 2.0 3.0 1.0
13 JJN18-03 2.0 2.0 2.0
14 JJN19-03 2.0 2.0 2.0
15 JJN20-01 2.5 2.5 1.0
16 JJT02-01 2.0 3.0 1.0
17 JJT02-04 2.5 2.5 1.0
18 JJT03-02 2.0 1.0 3.0
19 JJT07-03 2.5 1.0 2.5
20 JJT07-04 1.5 1.5 3.0
21 JJT09-01 2.0 3.0 1.0
22 JJT09-03 3.0 2.0 1.0
23 JJT10-02 3.0 2.0 1.0
24 JJT13-01 3.0 2.0 1.0
25 JJT12-02 2.0 3.0 1.0
26 JJT12-04 3.0 2.0 1.0
27 JJT17-05 2.0 1.0 3.0
28 JJT21-06 2.0 3.0 1.0
29 JJT24-04 2.0 3.0 1.0
30 JJT24-07 3.0 1.0 2.0
31 JJT24-09 2.0 3.0 1.0
32 JJT25-06 2.0 1.0 3.0
33 JJT27-04 3.0 2.0 1.0
34 JJT27-10 3.0 1.0 2.0
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CV Ranks for Different Features
Fold Dataset FLIM & OCT FLIM OCT
35 JJT28-11 3.0 1.0 2.0
36 JJT16-05 3.0 2.0 1.0
37 JJT16-10 3.0 1.0 2.0
38 JJT18-05 2.0 1.0 3.0
39 JJT18-06 2.0 2.0 2.0
40 JJT18-07 3.0 1.0 2.0
41 JJT23-04 3.0 2.0 1.0
42 JJT25-07 2.5 2.5 1.0
43 JJT26-06 3.0 2.0 1.0
44 JJT27-03 2.5 2.5 1.0
45 JJT28-06 3.0 1.0 2.0
46 JJT28-08 2.5 2.5 1.0
47 JJT28-12 3.0 2.0 1.0
48 JJT32-08 2.0 3.0 1.0
Mean Rank 2.5 2.0 1.5
169
